NZ740771B2 - Patient interface - Google Patents
Patient interface Download PDFInfo
- Publication number
- NZ740771B2 NZ740771B2 NZ740771A NZ74077116A NZ740771B2 NZ 740771 B2 NZ740771 B2 NZ 740771B2 NZ 740771 A NZ740771 A NZ 740771A NZ 74077116 A NZ74077116 A NZ 74077116A NZ 740771 B2 NZ740771 B2 NZ 740771B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- seal
- patient
- assembly
- frame assembly
- structured
- Prior art date
Links
- 210000001331 Nose Anatomy 0.000 claims abstract description 31
- 230000001815 facial Effects 0.000 claims abstract description 24
- 210000000214 Mouth Anatomy 0.000 claims abstract description 18
- 230000003068 static Effects 0.000 claims abstract description 14
- 239000003570 air Substances 0.000 claims description 146
- 210000001513 Elbow Anatomy 0.000 claims description 126
- 239000000463 material Substances 0.000 claims description 36
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 32
- 230000000241 respiratory Effects 0.000 claims description 30
- 238000002560 therapeutic procedure Methods 0.000 claims description 30
- 230000007958 sleep Effects 0.000 claims description 13
- 208000000927 Sleep Apnea Syndrome Diseases 0.000 claims description 11
- 238000003780 insertion Methods 0.000 claims description 11
- 239000012080 ambient air Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 description 107
- 210000000088 Lip Anatomy 0.000 description 29
- 238000009423 ventilation Methods 0.000 description 25
- 210000003128 Head Anatomy 0.000 description 24
- 239000007789 gas Substances 0.000 description 23
- 238000007789 sealing Methods 0.000 description 19
- 230000014759 maintenance of location Effects 0.000 description 17
- 210000000845 Cartilage Anatomy 0.000 description 16
- 230000003434 inspiratory Effects 0.000 description 15
- 230000003019 stabilising Effects 0.000 description 15
- 238000005452 bending Methods 0.000 description 14
- 230000000875 corresponding Effects 0.000 description 14
- 210000000988 Bone and Bones Anatomy 0.000 description 12
- 210000004373 Mandible Anatomy 0.000 description 12
- NOQGZXFMHARMLW-UHFFFAOYSA-N Succinic acid 2,2-dimethylhydrazide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 12
- 230000000712 assembly Effects 0.000 description 12
- 210000004072 Lung Anatomy 0.000 description 11
- 239000006260 foam Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 230000002093 peripheral Effects 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 10
- 210000002050 Maxilla Anatomy 0.000 description 9
- 210000003928 Nasal Cavity Anatomy 0.000 description 9
- 206010038683 Respiratory disease Diseases 0.000 description 9
- 229920000515 polycarbonate Polymers 0.000 description 9
- 239000004417 polycarbonate Substances 0.000 description 9
- 210000003467 Cheek Anatomy 0.000 description 8
- 210000004379 Membranes Anatomy 0.000 description 8
- 210000003205 Muscles Anatomy 0.000 description 8
- 230000023298 conjugation with cellular fusion Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000013011 mating Effects 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 201000004193 respiratory failure Diseases 0.000 description 8
- 230000021037 unidirectional conjugation Effects 0.000 description 8
- 208000006883 Neuromuscular Disease Diseases 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000001965 increased Effects 0.000 description 7
- 208000008784 Apnea Diseases 0.000 description 6
- 206010021079 Hypopnoea Diseases 0.000 description 6
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 6
- 239000004944 Liquid Silicone Rubber Substances 0.000 description 6
- 210000000537 Nasal Bone Anatomy 0.000 description 6
- 210000003437 Trachea Anatomy 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 229920002379 silicone rubber Polymers 0.000 description 6
- 206010002974 Apnoea Diseases 0.000 description 5
- 206010006334 Breathing abnormality Diseases 0.000 description 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 210000000867 Larynx Anatomy 0.000 description 5
- 208000001797 Obstructive Sleep Apnea Diseases 0.000 description 5
- 210000003800 Pharynx Anatomy 0.000 description 5
- 210000003491 Skin Anatomy 0.000 description 5
- 210000003625 Skull Anatomy 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 230000035812 respiration Effects 0.000 description 5
- 210000002345 respiratory system Anatomy 0.000 description 5
- 210000000621 Bronchi Anatomy 0.000 description 4
- 210000003123 Bronchioles Anatomy 0.000 description 4
- 210000001061 Forehead Anatomy 0.000 description 4
- 210000002184 Nasal Cartilages Anatomy 0.000 description 4
- 210000000614 Ribs Anatomy 0.000 description 4
- 229920002725 Thermoplastic elastomer Polymers 0.000 description 4
- 210000002105 Tongue Anatomy 0.000 description 4
- 206010067775 Upper airway obstruction Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 230000036961 partial Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000002644 respiratory therapy Methods 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 230000000087 stabilizing Effects 0.000 description 4
- 239000004753 textile Substances 0.000 description 4
- 241000083547 Columella Species 0.000 description 3
- 210000002454 Frontal Bone Anatomy 0.000 description 3
- 206010019233 Headache Diseases 0.000 description 3
- 208000000122 Hyperventilation Diseases 0.000 description 3
- 210000003026 Hypopharynx Anatomy 0.000 description 3
- 210000000492 Nasal Septum Anatomy 0.000 description 3
- 210000001584 Palate, Soft Anatomy 0.000 description 3
- 210000001260 Vocal Cords Anatomy 0.000 description 3
- ASCUXPQGEXGEMJ-GPLGTHOPSA-N [(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-methylanilino)oxan-2-yl]methoxy]oxan-2-yl]methyl acetate Chemical compound CC(=O)O[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@H]1OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](NC=2C=CC(C)=CC=2)O1 ASCUXPQGEXGEMJ-GPLGTHOPSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004874 lower jaw Anatomy 0.000 description 3
- 230000000414 obstructive Effects 0.000 description 3
- 230000003252 repetitive Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000001960 triggered Effects 0.000 description 3
- 210000004873 upper jaw Anatomy 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 2
- 206010006451 Bronchitis Diseases 0.000 description 2
- 230000037250 Clearance Effects 0.000 description 2
- 206010013801 Duchenne muscular dystrophy Diseases 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 210000000887 Face Anatomy 0.000 description 2
- 210000002216 Heart Anatomy 0.000 description 2
- 210000001847 Jaw Anatomy 0.000 description 2
- 101700015817 LAT2 Proteins 0.000 description 2
- 210000001989 Nasopharynx Anatomy 0.000 description 2
- 210000000103 Occipital Bone Anatomy 0.000 description 2
- 210000004279 Orbit Anatomy 0.000 description 2
- 210000003300 Oropharynx Anatomy 0.000 description 2
- 210000003455 Parietal Bone Anatomy 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 210000001738 Temporomandibular Joint Anatomy 0.000 description 2
- 210000000115 Thoracic Cavity Anatomy 0.000 description 2
- 210000000779 Thoracic Wall Anatomy 0.000 description 2
- 210000001944 Turbinates Anatomy 0.000 description 2
- 210000003932 Urinary Bladder Anatomy 0.000 description 2
- 210000000216 Zygoma Anatomy 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive Effects 0.000 description 2
- 230000001058 adult Effects 0.000 description 2
- 230000037007 arousal Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 230000035512 clearance Effects 0.000 description 2
- 230000000295 complement Effects 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 230000003340 mental Effects 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000000750 progressive Effects 0.000 description 2
- 200000000025 progressive disease Diseases 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 230000037321 sleepiness Effects 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 239000003351 stiffener Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000003519 ventilatory Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000000683 Abdominal Cavity Anatomy 0.000 description 1
- 108009000433 Amyotrophic lateral sclerosis (ALS) Proteins 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 208000001183 Brain Injury Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 208000008787 Cardiovascular Disease Diseases 0.000 description 1
- 208000003417 Central Sleep Apnea Diseases 0.000 description 1
- 208000007451 Chronic Bronchitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000264 Deglutition Disorders Diseases 0.000 description 1
- 206010013950 Dysphagia Diseases 0.000 description 1
- 210000002409 Epiglottis Anatomy 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 244000153665 Ficus glomerata Species 0.000 description 1
- 235000012571 Ficus glomerata Nutrition 0.000 description 1
- 210000002532 Foramen Magnum Anatomy 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000155250 Iole Species 0.000 description 1
- 241000229754 Iva xanthiifolia Species 0.000 description 1
- 206010023506 Kyphoscoliosis Diseases 0.000 description 1
- 206010024971 Lower respiratory tract infection Diseases 0.000 description 1
- 229920000079 Memory foam Polymers 0.000 description 1
- 241000121185 Monodon monoceros Species 0.000 description 1
- 206010027940 Mood altered Diseases 0.000 description 1
- 208000001022 Morbid Obesity Diseases 0.000 description 1
- 208000001705 Mouth Breathing Diseases 0.000 description 1
- 208000003627 Muscular Dystrophy Diseases 0.000 description 1
- 210000002850 Nasal Mucosa Anatomy 0.000 description 1
- 240000008962 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010073310 Occupational exposure Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010031123 Orthopnoea Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 210000003254 Palate Anatomy 0.000 description 1
- 210000001983 Palate, Hard Anatomy 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 210000003019 Respiratory Muscles Anatomy 0.000 description 1
- 206010070833 Respiratory muscle weakness Diseases 0.000 description 1
- 241001016288 Sesamoides Species 0.000 description 1
- 206010040979 Sleep apnoea syndrome Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 210000003802 Sputum Anatomy 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 210000004243 Sweat Anatomy 0.000 description 1
- 210000003582 Temporal Bone Anatomy 0.000 description 1
- 229940035295 Ting Drugs 0.000 description 1
- 241000746998 Tragus Species 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005534 acoustic noise Effects 0.000 description 1
- 230000003044 adaptive Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- XSXWYGABGYBZRM-UHFFFAOYSA-N carbonic acid;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound OC(O)=O.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 XSXWYGABGYBZRM-UHFFFAOYSA-N 0.000 description 1
- 230000002612 cardiopulmonary Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001808 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 238000002567 electromyography Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 230000001146 hypoxic Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000000977 initiatory Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000010807 litter Substances 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000008210 memory foam Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 230000003274 myotonic Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 230000001936 parietal Effects 0.000 description 1
- 244000144985 peep Species 0.000 description 1
- 229920002854 poly(ethyl ethoxyethylene phosphate) polymer Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000002685 pulmonary Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000036412 respiratory physiology Effects 0.000 description 1
- 230000000284 resting Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 230000001020 rhythmical Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 238000010321 sleep therapy Methods 0.000 description 1
- 230000000391 smoking Effects 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000000153 supplemental Effects 0.000 description 1
- 230000000152 swallowing Effects 0.000 description 1
- 230000002889 sympathetic Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002747 voluntary Effects 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0057—Pumps therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0605—Means for improving the adaptation of the mask to the patient
- A61M16/0616—Means for improving the adaptation of the mask to the patient with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0605—Means for improving the adaptation of the mask to the patient
- A61M16/0616—Means for improving the adaptation of the mask to the patient with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure
- A61M16/0622—Means for improving the adaptation of the mask to the patient with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure having an underlying cushion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0683—Holding devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0683—Holding devices therefor
- A61M16/0694—Chin straps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0875—Connecting tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0085—Special media to be introduced, removed or treated product washed out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/42—Reducing noise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0618—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0625—Mouth
Abstract
patient interface includes a frame assembly 16100 including connectors operatively attachable to headgear, a cushion assembly 16175 including a shell 161800 and a seal-forming structure 16200 structured to form a seal with the patient's nose and/or mouth, and an air delivery connector 16600. The cushion assembly and air delivery connector are structured to releasably connect to the frame assembly independently of each other. A static face seal and separate static diametric seal between the shell 161800 and frame. A dynamic face seal and separate dynamic diametric seal between the air delivery connector 16600 and frame 16100. Separate claims to a frame assembly 16100 as in Fig 6, with upper headgear connector arms 16134 including at least one slot 6146 (claim 17) or flexible portions (claim 22) to form hinges structured and arranged to conform to varying facial profiles. ushion assembly and air delivery connector are structured to releasably connect to the frame assembly independently of each other. A static face seal and separate static diametric seal between the shell 161800 and frame. A dynamic face seal and separate dynamic diametric seal between the air delivery connector 16600 and frame 16100. Separate claims to a frame assembly 16100 as in Fig 6, with upper headgear connector arms 16134 including at least one slot 6146 (claim 17) or flexible portions (claim 22) to form hinges structured and arranged to conform to varying facial profiles.
Description
PATIENT ACE
l CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Application No.
62/222,593, filed September 23, 2015, and U.S. Provisional Application No.
62/376,961, filed August 19, 2016, each of which is incorporated herein by reference
in its entirety.
2 BACKGROUND OF THE TECHNOLOGY
2.1 FIELD OF THE TECHNOLOGY
The present technology relates to one or more of the detection, diagnosis,
treatment, prevention and amelioration of atory—related ers. The present
technology also relates to medical s or apparatus, and their use.
2.2 DESCRIPTION OF THE RELATED ART
2.2.1 Human Respiratory System and its Disorders
The respiratory system of the body tates gas exchange. The nose and
mouth form the entrance to the airways of a patient.
The airways include a series of branching tubes, which become narrower,
shorter and more numerous as they penetrate deeper into the lung. The prime function
of the lung is gas exchange, allowing oxygen to move from the air into the venous
blood and carbon dioxide to move out. The trachea divides into right and left main
bronchi, which further divide eventually into terminal ioles. The bronchi make
up the conducting s, and do not take part in gas exchange. Further ons of
the airways lead to the respiratory bronchioles, and eventually to the alveoli. The
alveolated region of the lung is where the gas exchange takes place, and is referred to
as the respiratory zone. See “Respiratory Physiology”, by John B. West, cott
Williams & Wilkins, 9th edition published 2011.
A range of respiratory disorders exist. Certain disorders may be
characterised by particular events, e.g. apneas, hypopneas, and hyperpneas.
Obstructive Sleep Apnea (OSA), a form of Sleep Disordered Breathing
(SDB), is terized by events including occlusion or obstruction of the upper air
passage during sleep. It results from a combination of an abnormally small upper
airway and the normal loss of muscle tone in the region of the tongue, soft palate and
posterior oropharyngeal wall during sleep. The condition causes the affected patient to
stop breathing for periods typically of 30 to 120 seconds in duration, sometimes 200
to 300 times per night. It often causes excessive daytime ence, and it may
cause cardiovascular disease and brain damage. The syndrome is a common er,
particularly in middle aged overweight males, although a person affected may have no
ess of the problem. See US Patent No. 4,944,310 (Sullivan).
Cheyne—Stokes ation (CSR) is another form of sleep disordered
breathing. CSR is a er of a patient's respiratory controller in which there are
rhythmic alternating periods of waxing and waning ventilation known as CSR cycles.
CSR is characterised by repetitive de—oxygenation and re—oxygenation of the arterial
blood. It is possible that CSR is harmful because of the repetitive hypoxia. In some
patients CSR is associated with repetitive arousal from sleep, which causes severe
sleep disruption, increased sympathetic activity, and increased afterload. See US
Patent No. 6,532,959 (Berthon—Jones).
Respiratory failure is an umbrella term for respiratory disorders in which
the lungs are unable to inspire sufficient oxygen or exhale sufficient COZ to meet the
patient’s needs. Respiratory failure may encompass some or all of the following
disorders.
A patient with respiratory insufficiency (a form of atory failure) may
experience abnormal shortness of breath on exercise.
Obesity Hyperventilation me (OHS) is defined as the combination
of severe obesity and awake chronic hypercapnia, in the absence of other known
causes for hypoventilation. Symptoms e dyspnea, morning headache and
excessive e sleepiness.
c Obstructive Pulmonary e (COPD) encompasses any of a
group of lower airway diseases that have certain characteristics in common. These
include increased ance to air movement, extended expiratory phase of
respiration, and loss of the normal elasticity of the lung. Examples of COPD are
ema and chronic bronchitis. COPD is caused by chronic tobacco smoking
(primary risk factor), occupational exposures, air pollution and genetic factors.
ms include: dyspnea on exertion, chronic cough and sputum production.
Neuromuscular Disease (NMD) is a broad term that asses many
es and ailments that impair the functioning of the muscles either directly via
intrinsic muscle pathology, or indirectly via nerve pathology. Some NMD patients are
characterised by ssive muscular impairment leading to loss of ambulation,
being wheelchair—bound, swallowing difficulties, respiratory muscle weakness and,
eventually, death from respiratory failure. Neuromuscular disorders can be divided
into rapidly progressive and slowly progressive: (i) Rapidly progressive disorders:
Characterised by muscle impairment that worsens over months and results in death
within a few years (e.g. Amyotrophic lateral sclerosis (ALS) and Duchenne muscular
dystrophy (DMD) in teenagers); (ii) Variable or slowly progressive disorders:
terised by muscle impairment that worsens over years and only mildly reduces
life expectancy (e.g. Limb girdle, Facioscapulohumeral and Myotonic muscular
dystrophy). Symptoms of respiratory failure in NMD include: increasing generalised
ss, dysphagia, dyspnea on exertion and at rest, fatigue, sleepiness, morning
headache, and difficulties with concentration and mood changes.
Chest wall disorders are a group of ic deformities that result in
inefficient coupling between the respiratory muscles and the thoracic cage. The
ers are usually characterised by a restrictive defect and share the potential of
long term hypercapnic respiratory failure. sis and/or kyphoscoliosis may cause
severe respiratory e. Symptoms of respiratory failure e: dyspnea on
exertion, peripheral oedema, orthopnea, repeated chest infections, morning headaches,
fatigue, poor sleep y and loss of te.
A range of therapies have been used to treat or ameliorate such conditions.
Furthermore, otherwise healthy individuals may take advantage of such therapies to
prevent respiratory disorders from arising. However, these have a number of
shortcomings.
2.2.2 Therapy
Continuous Positive Airway Pressure (CPAP) therapy has been used to
treat Obstructive Sleep Apnea (OSA). The mechanism of action is that continuous
positive airway pressure acts as a pneumatic splint and may prevent upper airway
occlusion, such as by pushing the soft palate and tongue forward and away from the
posterior oropharyngeal wall. Treatment of OSA by CPAP therapy may be voluntary,
and hence patients may elect not to comply with therapy if they find devices used to
provide such therapy one or more of: uncomfortable, difficult to use, expensive and
aesthetically unappealing.
Non—invasive ventilation (NIV) es atory support to a patient
through the upper airways to assist the patient breathing and/or maintain adequate
oxygen levels in the body by doing some or all of the work of breathing. The
ventilatory support is provided via a non—invasive patient interface. NIV has been
used to treat CSR and respiratory failure, in forms such as OHS, COPD, NMD and
Chest Wall disorders. In some forms, the comfort and effectiveness of these therapies
may be improved.
ve ventilation (IV) provides ventilatory support to ts that are
no longer able to ively breathe lves and may be provided using a
tracheostomy tube. In some forms, the comfort and effectiveness of these therapies
may be improved.
2.2.3 Treatment Systems
These ies may be provided by a ent system or device. Such
systems and devices may also be used to diagnose a condition without treating it.
A treatment system may se a Respiratory Pressure Therapy Device
(RPT device), an air circuit, a humidifier, a patient interface, and data management.
Another form of ent system is a mandibular tioning device.
2.2.3.1 Patient Interface
A patient interface may be used to interface respiratory equipment to its
wearer, for example by providing a flow of air to an entrance to the airways. The flow
of air may be provided via a mask to the nose and/or mouth, a tube to the mouth or a
tracheostomy tube to the trachea of a patient. Depending upon the therapy to be
applied, the patient interface may form a seal, e.g., with a region of the patient's face,
to tate the delivery of gas at a pressure at sufficient variance with ambient
pressure to effect therapy, e.g., at a positive pressure of about 10 cmHzO relative to
ambient pressure. For other forms of therapy, such as the delivery of oxygen, the
patient interface may not e a seal sufficient to facilitate delivery to the s
of a supply of gas at a ve pressure of about 10 cmHZO.
Certain other mask systems may be onally unsuitable for the present
field. For example, purely ornamental masks may be unable to maintain a suitable
pressure. Mask systems used for underwater swimming or diving may be configured
to guard against ingress of water from an external higher pressure, but not to maintain
air internally at a higher pressure than ambient.
Certain masks may be clinically unfavourable for the t technology
e. g. if they block airflow via the nose and only allow it via the mouth.
Certain masks may be uncomfortable or impractical for the present
technology if they require a patient to insert a portion of a mask structure in their
mouth to create and in a seal via their lips.
Certain masks may be impractical for use while sleeping, e.g. for sleeping
while lying on one’s side in bed with a head on a pillow.
The design of a patient interface presents a number of challenges. The
face has a complex three—dimensional shape. The size and shape of noses and heads
varies considerably between individuals. Since the head includes bone, cartilage and
soft tissue, different regions of the face respond ently to mechanical forces. The
jaw or mandible may move relative to other bones of the skull. The whole head may
move during the course of a period of respiratory therapy.
As a uence of these challenges, some masks suffer from being one
or more of obtrusive, aesthetically undesirable, costly, poorly fitting, difficult to use,
and uncomfortable especially when worn for long periods of time or when a patient is
unfamiliar with a system. y sized masks can give rise to d compliance,
2016/050891
reduced t and poorer patient es. Masks designed solely for aviators,
masks designed as part of personal protection equipment (e.g. filter masks), SCUBA
masks, or for the administration of anaesthetics may be tolerable for their original
application, but nevertheless such masks may be undesirably uncomfortable to be
worn for extended periods of time, e.g., several hours. This discomfort may lead to a
reduction in patient compliance with therapy. This is even more so if the mask is to
be worn during sleep.
CPAP therapy is highly effective to treat certain respiratory disorders,
provided patients comply With therapy. If a mask is uncomfortable, or difficult to use
a patient may not comply with y. Since it is often recommended that a patient
regularly wash their mask, if a mask is difficult to clean (e.g., difficult to assemble or
disassemble), patients may not clean their mask and this may impact on t
compliance.
While a mask for other applications (e.g. aviators) may not be suitable for
use in treating sleep disordered breathing, a mask designed for use in treating sleep
disordered breathing may be suitable for other applications.
For these reasons, patient interfaces for delivery of CPAP during sleep
form a distinct field.
2.2.3.1.] Seal-forming portion
Patient interfaces may e a seal—forming portion. Since it is in direct
contact with the patient’s face, the shape and configuration of the seal—forming
n can have a direct impact the effectiveness and t of the patient interface.
A patient interface may be partly characterised according to the design
intent of Where the seal—forming portion is to engage with the face in use. In one form
of patient interface, a seal—forming portion may comprise two sub—portions to engage
with respective left and right nares. In one form of patient interface, a seal—forming
portion may comprise a single element that surrounds both nares in use. Such single
element may be designed to for example overlay an upper lip region and a nasal
bridge region of a face. In one form of t interface a seal—forming n may
comprise an element that surrounds a mouth region in use, e.g. by forming a seal on a
lower lip region of a face. In one form of patient interface, a seal—forming portion may
comprise a single element that surrounds both nares and a mouth region in use. These
different types of patient interfaces may be known by a variety of names by their
manufacturer including nasal masks, full—face masks, nasal pillows, nasal puffs and
oro—nasal masks.
A seal—forming portion that may be effective in one region of a patient’s
face may be inappropriate in r region, e.g. because of the different shape,
structure, variability and sensitivity regions of the patient’s face. For example, a seal
on swimming goggles that overlays a patient’s ad may not be appropriate to use
on a patient’s nose.
Certain seal—forming portions may be designed for mass manufacture such
that one design fit and be comfortable and effective for a wide range of different face
shapes and sizes. To the extent to which there is a mismatch between the shape of the
patient’s face, and the seal—forming portion of the mass—manufactured t
interface, one or both must adapt in order for a seal to form.
One type of seal—forming n extends around the periphery of the
t interface, and is intended to seal t the patient's face when force is
applied to the patient interface with the seal—forming n in confronting
engagement with the patient's face. The seal—forming portion may e an air or
fluid filled n, or a moulded or formed surface of a resilient seal element made
of an elastomer such as a rubber. With this type of seal—forming portion, if the fit is
not adequate, there will be gaps between the seal—forming portion and the face, and
additional force will be required to force the patient interface against the face in order
to achieve a seal.
Another type of seal—forming portion incorporates a flap seal of thin
al positioned about the periphery of the mask so as to provide a self—sealing
action against the face of the patient when positive pressure is applied within the
mask. Like the us style of seal forming portion, if the match n the face
and the mask is not good, additional force may be required to achieve a seal, or the
mask may leak. Furthermore, if the shape of the seal—forming portion does not match
that of the patient, it may crease or buckle in use, giving rise to leaks.
Another type of seal—forming portion may comprise a friction—fit element,
e.g. for insertion into a naris, however some patients find these ortable.
Another form of seal—forming portion may use ve to achieve a seal.
Some patients may find it inconvenient to constantly apply and remove an adhesive to
their face.
A range of t interface orming portion technologies are
disclosed in the following patent applications, ed to ResMed Limited: WO
l998/004,310; ,513; ,785.
One form of nasal pillow is found in the Adam Circuit manufactured by
n Bennett. Another nasal pillow, or nasal puff is the subject of US Patent
4,782,832 (Trimble er al.), assigned to Puritan—Bennett Corporation.
ResMed Limited has manufactured the following products that
incorporate nasal pillows: SWIFTTM nasal pillows mask, SWIFTTM II nasal pillows
mask, SWIFTTM LT nasal pillows mask, SWIFTTM FX nasal pillows mask and
MIRAGE LIBERTYTM full—face mask. The following patent applications, assigned to
ResMed d, describe es of nasal pillows masks: International Patent
Application W02004/073,778 (describing amongst other things aspects of the
ResMed Limited SWIFTTM nasal pillows), US Patent Application 2009/0044808
(describing amongst other things aspects of the ResMed Limited SWIFTTM LT nasal
pillows); International Patent Applications ,328 and WC 2006/130,903
(describing amongst other things aspects of the ResMed Limited MIRAGE
LIBERTYTM full—face mask); International Patent ation ,560
(describing amongst other things aspects of the ResMed Limited SWIFTTM FX nasal
pillows).
2.2.3.1.2 oning and stabilising
A seal—forming portion of a patient interface used for positive air pressure
y is subject to the corresponding force of the air pressure to disrupt a seal. Thus
a y of techniques have been used to position the seal—forming portion, and to
maintain it in sealing relation with the appropriate portion of the face.
One technique is the use of ves. See for example US Patent
Application Publication No. US 2010/0000534. However, the use of adhesives may
be uncomfortable for some.
r technique is the use of one or more straps and/or stabilising
harnesses. Many such ses suffer from being one or more of ill—fitting, bulky,
uncomfortable and awkward to use.
2.2.3.2 Respiratory re y (RPT) Device
Air pressure generators are known in a range of applications, e.g.
industrial—scale ventilation s. However, air pressure generators for medical
applications have particular requirements not fulfilled by more generalised air
pressure generators, such as the reliability, size and weight requirements of medical
devices. In addition, even s designed for medical treatment may suffer from
shortcomings, pertaining to one or more of: comfort, noise, ease of use, cy, size,
weight, manufacturability, cost, and reliability.
An example of the special requirements of certain RPT devices is acoustic
noise.
Table of noise output levels of prior RPT devices (one specimen only,
measured using test method specified in ISO 3744 in CPAP mode at 10 cmHzO).
RPT Device name A—weighted sound Year (approx.)
‘ 5
pressure level dB (A)
''''''''''''''''''''''''''''''''''''''''''''''
""Eiséfiééfifi'gBTM 3192007
....C—SeriesTangoIMw1thHum1d1f1er3312007
S8EscapeTMH............................................................... '30-'5-........................................................... 2005
S8EscapeTMIIw1thH41TMHumid1f1er3ll2005““““““““““““““““
S9AutoSet1M26500000000000000000000000000000000000000000000000000000000000 2010
S9AutoSetTMw1thH51Hum1d1f1er2862010
............................................................................................................................................................................................................................
One known RPT device used'for treating sleep disordered breathing is the
S9 Sleep Therapy System, manufactured by ResMed Limited. Another example of an
RPT device is a ventilator. Ventilators such as the ResMed StellarTM Series of Adult
and Paediatric Ventilators may provide support for invasive and non—invasive non—
WO 49356
dependent ventilation for a range of patients for treating a number of conditions such
as but not limited to NMD, OHS and COPD.
The ResMed EliseeTM l50 ator and ResMed VS IIITM ator may
provide t for ve and non—invasive dependent ventilation suitable for adult
or paediatric patients for treating a number of conditions. These ventilators provide
volumetric and barometric ventilation modes with a single or double limb circuit.
RPT devices typically comprise a pressure generator, such as a motor—driven blower
or a compressed gas reservoir, and are configured to supply a flow of air to the airway
of a patient. In some cases, the flow of air may be supplied to the airway of the patient
at positive pressure. The outlet of the RPT device is connected via an air circuit to a
patient interface such as those described above.
The designer of a device may be presented with an infinite number of
choices to make. Design criteria often conflict, meaning that certain design choices
are far from e or inevitable. Furthermore, the comfort and efficacy of certain
aspects may be highly sensitive to small, subtle changes in one or more parameters.
2.2.3.3 fier
Delivery of a flow of air without fication may cause drying of
airways. The use of a humidifier with an RPT device and the patient interface
produces humidified gas that minimizes drying of the nasal mucosa and increases
patient airway comfort. In addition in cooler climates, warm air applied generally to
the face area in and about the patient interface is more comfortable than cold air. A
range of artificial humidification devices and systems are known, however they may
not fulfil the specialised requirements of a medical humidifier.
Medical humidifiers are used to increase ty and/or temperature of
the flow of air in relation to ambient air when required, typically where the patient
may be asleep or resting (e.g. at a al). A medical humidifier for bedside
placement may be small. A medical humidifier may be configured to only humidify
and/or heat the flow of air delivered to the patient without humidifying and/or g
the patient’s surroundings. Room—based s (e.g. a sauna, an air ioner, or
an evaporative cooler), for example, may also humidify air that is breathed in by the
patient, however those systems would also humidify and/or heat the entire room,
which may cause discomfort to the occupants. Furthermore l humidifiers may
have more stringent safety constraints than industrial humidifiers
While a number of medical humidifiers are known, they can suffer from
one or more shortcomings. Some medical humidifiers may provide inadequate
humidification, some are difficult or inconvenient to use by patients.
2.2.3.4 Data Management
There may be clinical s to obtain data to determine whether the
patient prescribed with respiratory therapy has been “compliant”, e.g. that the patient
has used their RPT device according to certain a “compliance rule”. One example of a
compliance rule for CPAP therapy is that a patient, in order to be deemed compliant,
is required to use the RPT device for at least four hours a night for at least 21 of 30
consecutive days. In order to determine a patient's compliance, a provider of the RPT
device, such as a health care provider, may manually obtain data describing the
patient's y using the RPT device, calculate the usage over a predetermined time
period, and compare with the compliance rule. Once the health care provider has
determined that the patient has used their RPT device according to the compliance
rule, the health care provider may notify a third party that the patient is compliant.
There may be other aspects of a patient’s y that would benefit from
communication of therapy data to a third party or external .
ng ses to communicate and manage such data can be one or
more of costly, time—consuming, and error—prone.
2.2.3.5 Mandibular repositioning
A mandibular repositioning device (MRD) or ular advancement
device (MAD) is one of the treatment options for sleep apnea and snoring. It is an
adjustable oral appliance available from a dentist or other supplier that holds the
lower jaw (mandible) in a forward position during sleep. The MRD is a removable
device that a patient inserts into their mouth prior to going to sleep and removes
following sleep. Thus, the MRD is not designed to be worn all of the time. The
MRD may be custom made or produced in a standard form and es a bite
impression portion designed to allow fitting to a t’s teeth. This mechanical
WO 49356
protrusion of the lower jaw expands the space behind the tongue, puts tension on the
pharyngeal walls to reduce collapse of the airway and diminishes palate vibration.
In certain examples a mandibular advancement device may comprise an
upper splint that is intended to engage with or fit over teeth on the upper jaw or
maxilla and a lower splint that is intended to engage with or fit over teeth on the upper
jaw or mandible. The upper and lower splints are connected together laterally via a
pair of connecting rods. The pair of connecting rods are fixed symmetrically on the
upper splint and on the lower splint.
In such a design the length of the connecting rods is selected such that
when the MRD is placed in a t’s mouth the mandible is held in an ed
position. The length of the connecting rods may be adjusted to change the level of
protrusion of the mandible. A dentist may determine a level of sion for the
mandible that will determine the length of the connecting rods.
Some MRDs are structured to push the mandible forward relative to the
maxilla while other MADs, such as the ResMed Narval CCTM MRD are designed to
retain the mandible in a forward position. This device also s or minimises
dental and temporo—mandibular joint (TMJ) side effects. Thus, it is configured to
minimises or prevent any movement of one or more of the teeth.
6 Vent technologies
Some forms of treatment s may include a vent to allow the washout
of exhaled carbon dioxide. The vent may allow a flow of gas from an or space of
a patient interface, e. g., the plenum chamber, to an exterior of the patient interface,
e. g., to ambient. The vent may comprise an orifice and gas may flow through the
orifice in use of the mask. Many such vents are noisy. Others may become blocked in
use and thus provide icient washout. Some vents may be disruptive of the sleep
of a bed partner 1100 of the patient 1000, e.g. through noise or focussed airflow.
ResMed Limited has developed a number of improved mask vent
technologies. See International Patent Application Publication No. ,665;
International Patent Application Publication No. ,381; US Patent No.
6,581,594; US Patent Application ation No. US 2009/0050156; US Patent
Application Publication No. 044808.
Table of noise of prior masks (ISO 17510—22007, 10 cmHzO pressure at
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
A—Weighted A—Weighted
sound power sound pressure
level dB(A) ;dB<A>
(uncertainty) (uncertainty)
Uu.u.u.u.u.u.u.u.u.u.u.u.u.u.upu.u.u.u.u.u.u.u.u.u.u.u.u.u.......................................................................................................................................
x....................................................................................................................................x............................................4...........................................
ResCare
standard (*)
t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,“,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,‘,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
«--------------------------------------------<------------------------------------------........................................................................................................................................
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
d\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\«\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\4
sdddddd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\«\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\dd\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\4
M....................................................................................................................................&............................................ .............................................
k ( )
t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,“,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,‘,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
k 1:]
t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,“,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,‘,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
gMirage SW1ft- -
k I I
t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,“,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,‘,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,t,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ResMed AirFit
(* one specimen only, measured using test method specified in ISO 3744
in CPAP mode at 10 cmHzO)Sound re values of a variety of objects are listed
below
Vacuum cleaner: Nilfisk 68 ISO 3744 at lm
Walter Broadly Litter Hog: B+ distance
Grade E g
‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘[‘ifii‘fii‘éafiéé“““““““““““““““““““
sationalspeech60
......................................................................................................................................................
Averagehome50
.................................................40.....................................................................................................................................................
Quietlibrary
‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘‘
Quietbedroomatnight30
‘“13‘ae‘rgiaaha‘{H‘rvg‘t‘aaiaiiiiiiiiiiiiiiiiiiiii6iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
2.2.4 Diagnosis and Monitoring Systems
Polysomnography (PSG) is a conventional system for diagnosis and
ring of cardio—pulmonary disorders, and typically involves expert clinical staff
to apply the system. PSG typically involves the ent of 15 to 20 contact sensors
on a person in order to record various bodily signals such as electroencephalography
(EEG), electrocardiography (ECG), electrooculograpy (EOG), electromyography
(EMG), etc. PSG for sleep disordered breathing has involved two nights of
observation of a patient in a , one night of pure diagnosis and a second night of
titration of treatment parameters by a clinician. PSG is therefore ive and
inconvenient. In particular it is unsuitable for home sleep g.
Clinical experts may be able to diagnose or r patients adequately
based on visual observation of PSG signals. However, there are circumstances where
a clinical expert may not be available, or a clinical expert may not be affordable.
Different clinical experts may ee on a patient’s condition. In addition, a given
clinical expert may apply a different standard at different times.
3 BRIEF SUMMARY OF THE TECHNOLOGY
The present technology is directed towards providing medical devices
used in the diagnosis, amelioration, treatment, or tion of respiratory disorders
having one or more of improved comfort, cost, efficacy, ease of use and
manufacturability.
A first aspect of the present technology relates to apparatus used in the
diagnosis, amelioration, treatment or prevention of a atory disorder.
Another aspect of the present technology relates to methods used in the
diagnosis, amelioration, treatment or prevention of a respiratory disorder.
An aspect of certain forms of the t technology is to provide methods
and/or apparatus that improve the compliance of patients with respiratory therapy.
An aspect of the t logy relates to a patient interface including
a frame assembly including connectors operatively attachable to ar, a cushion
assembly provided to the frame assembly, the cushion assembly including a seal—
forming structure structured to form a seal with the patient’s nose and/or mouth, and
an air delivery tor provided to the frame assembly, the air delivery connector
operatively connected to an air delivery tube for supplying the air at positive pressure
along an air flow path. The cushion assembly is structured to releasably t to
the frame assembly independently of the air delivery connector. The air delivery
connector is structured to releasably connect to the frame assembly independently of
the cushion assembly.
In an example, a first seal for the air flow path may be formed n
the air delivery connector and the frame assembly. In an example, a second seal may
be formed n the frame assembly and the cushion assembly. In an example, the
first seal comprises a dynamic ric seal and a dynamic face seal. In an example,
the second seal comprises a static ric seal and a static face seal. In an example,
the air delivery connector is structured to engage the cushion assembly to provide a
seal for the air flow path. In an example, the cushion assembly includes a lip seal
structured to provide the seal with the air delivery connector. In an example, the air
delivery tor includes an elbow assembly. In an example, the elbow assembly
is adapted to swivel relative to the frame assembly. In an example, the air delivery
connector includes a vent adaptor tor. In an example, the air delivery
connector includes a pair of quick release spring arms structured and arranged to
releasably t to the frame assembly. In an example, the cushion assembly
includes a shell provided to the seal—forming structure, the shell and the seal—forming
ure cooperating to form a plenum chamber. In an example, the frame assembly
includes an upper headgear connector structured to connect to upper straps of the
headgear and a lower headgear connector structured to connect to lower straps of the
headgear. In an e, the upper ar connector includes a pair of upper
headgear connector arms, each of the arms including one or more flexible portions
structured and arranged to conform to varying facial profiles. In an example, each of
the flexible portions includes one or more slots structured to form one or more hinges.
In an example, the lower headgear connector includes a pair of lower headgear
connector arms, each of the lower ar tor arms including a magnetic
connector structured to connect to a magnetic headgear clip. In an example, each of
the lower headgear connector arms comprises a slot structured to form a hinge
portion. In an example, the frame assembly includes a relatively hard shroud, and the
upper and lower headgear tors are provided to the shroud. In an example, the
shroud includes upper and lower grooves structured to receive respective upper and
lower headgear connectors. In an example, the frame assembly is provided in one
size and is structured to be selectively engageable with multiple sizes of the cushion
assembly. In an example, the frame assembly includes a lockout feature along the air
flow path structured and arranged to prevent direct connection or insertion of the air
delivery tube. In an example, the lockout feature comprises a ity of projections
structured and ed to extend towards the air flow path. In an example, the
lockout feature comprises a single annular projection structured and ed to
extend towards the air flow path. In an example, the air delivery connector includes
an elbow assembly comprising a plurality of vent holes and an anti—asphyxia valve
assembly. In an example, the frame ly is ed in the air flow path.
Another aspect of the present technology relates to a frame assembly for a
patient interface including an upper headgear connector structured to t to upper
straps of headgear. The upper headgear connector includes a pair of upper headgear
connector arms, each of the arms ing one or more flexible ns structured
and arranged to conform to varying facial profiles.
In an example, each of the flexible portions includes one or more slots
structured to form one or more . In an e, each upper ar connector
arm es a first e portion and a second flexible portion between the first
flexible portion and an upper headgear connection point structured to connect to a
tive upper strap. In an example, the first flexible portion includes a single slot
and the second flexible portion includes a plurality of slots. In an example, the frame
ly further comprises a lower headgear connector structured to connect to lower
straps of headgear, the lower headgear connector including a pair of lower headgear
connector arms.
In yet another example, there is a provided a frame assembly for a patient
interface, comprising an upper headgear connector structured to connect to upper straps
of headgear, the upper headgear connector including a pair of upper ar connector
arms, each of the arms ing a plurality of flexible portions structured and arranged to
conform to varying facial profiles, wherein each of the flexible portions forms a plurality of
hinges.
Another aspect of the present technology relates to a t interface
including a frame assembly including tors operatively attachable to headgear, a
cushion assembly provided to the frame assembly, the cushion assembly including a
seal—forming structure ured to form a seal with the patient’s nose and/or mouth,
and an air delivery connector (e.g., elbow assembly) provided to the frame assembly,
the air delivery connector operatively connected to an air delivery tube for ing
the air at positive pressure. In an example, a first seal for the air flow path is formed
between the elbow assembly and the frame assembly, and a separate second seal is
formed between the frame assembly and the cushion assembly. For example, the
elbow assembly is structured to ish a hard—to—hard connection and dynamic seal
with the frame assembly, and the cushion assembly is structured to establish a
separate hard—to—hard connection and static seal with the frame assembly.
Another aspect of the present technology relates to a t ace
including a frame assembly including connectors operatively attachable to headgear, a
cushion assembly provided to the frame assembly, the cushion assembly including a
seal—forming structure structured to form a seal with the patient’s nose and/or mouth,
and an air delivery connector (e.g., elbow assembly) provided to the frame assembly,
the air delivery connector operatively connected to an air delivery tube for supplying
the air at ve pressure. In an example, the frame assembly includes a lockout
feature along the opening of the air flow path that is structured and ed to
prevent direct connection or insertion of the air delivery tube. This arrangement
requires use of the elbow assembly to interconnect the frame assembly and the air
delivery tube, thereby ng that the elbow assembly (e.g., and its vent and anti—
asphyxia valve (AAV)) are t in the system.
Another aspect of one form of the present technology is a patient interface
that is moulded or otherwise constructed with a perimeter shape which is
complementary to that of an ed .
An aspect of one form of the present technology is a method of
manufacturing apparatus.
An aspect of certain forms of the present technology is a l device
that is easy to use, e.g. by a person who does not have medical training, by a person
who has limited dexterity, vision or by a person with limited experience in using this
type of medical device.
An aspect of one form of the present technology is a patient interface that
may be washed in a home of a patient, e.g., in soapy water, without requiring
specialised ng equipment.
The methods/systems/devices/apparatus described herein can provide
improved oning in a processor, such as of a processor of a specific purpose
computer, respiratory monitor and/or a respiratory y apparatus. Moreover, the
methods/devices/apparatus can provide improvements in the technological field of
automated management, monitoring and/or treatment of respiratory conditions,
including, for example, sleep disordered breathing.
Of course, portions of the aspects may form pects of the present
technology. Also, various ones of the sub—aspects and/or aspects may be combined in
various manners and also constitute additional aspects or sub—aspects of the present
technology.
Other features of the technology will be apparent from consideration of
the information ned in the following detailed description, abstract, drawings and
claims.
4 BRIEF DESCRIPTION OF THE DRAWINGS
The present technology is illustrated by way of example, and not by way
of limitation, in the figures of the accompanying drawings, in which like reference
numerals refer to similar ts including:
4.1 TREATMENT SYSTEMS
Fig. 1A shows a system including a patient 1000 wearing a patient
interface 3000, in the form of a nasal pillows, receiving a supply of air at positive
pressure from an RPT device 4000. Air from the RPT device 4000 is humidified in a
humidifier 5000, and passes along an air circuit 4170 to the t 1000. A bed
partner 1100 is also shown.
Fig. 1B shows a system including a patient 1000 wearing a patient
interface 3000, in the form of a nasal mask, receiving a supply of air at ve
pressure from an RPT device 4000. Air from the RPT device is humidified in a
humidifier 5000, and passes along an air circuit 4170 to the patient 1000.
Fig. 1C shows a system ing a patient 1000 wearing a patient
interface 3000, in the form of a full—face mask, receiving a supply of air at positive
pressure from an RPT device 4000. Air from the RPT device is fied in a
humidifier 5000, and passes along an air circuit 4170 to the t 1000.
4.2 RESPIRATORY SYSTEM AND FACIAL ANATOMY
Fig. 2A shows an overview of a human respiratory system including the
nasal and oral cavities, the larynx, vocal folds, oesophagus, trachea, bronchus, lung,
alveolar sacs, heart and agm.
Fig. 2B shows a view of a human upper airway including the nasal cavity,
nasal bone, lateral nasal cartilage, greater alar cartilage, nostril, lip superior, lip
inferior, larynx, hard palate, soft palate, oropharynx, tongue, epiglottis, vocal folds,
oesophagus and trachea.
Fig. 2C is a front view of a face with several features of surface anatomy
identified including the lip superior, upper ion, lower vermilion, lip inferior,
mouth width, endocanthion, a nasal ala, nasolabial sulcus and cheilion. Also indicated
are the directions superior, inferior, radially inward and radially outward.
Fig. 2D is a side view of a head with several features of surface anatomy
identified including glabella, sellion, pronasale, subnasale, lip superior, lip inferior,
supramenton, nasal ridge, alar crest point, otobasion superior and ion inferior.
Also indicated are the directions superior & inferior, and or & posterior.
Fig. 2E is a further side view of a head. The approximate locations of the
Frankfort horizontal and nasolabial angle are indicated. The coronal plane is also
indicated.
Fig. 2F shows a base view of a nose with several features identified
including naso—labial sulcus, lip inferior, upper Vermilion, naris, subnasale,
columella, pronasale, the major axis of a naris and the sagittal plane.
Fig. 2G shows a side view of the superficial features of a nose.
Fig. 2H shows subcutaneal structures of the nose, including lateral
cartilage, septum cartilage, greater alar cartilage, lesser alar cartilage, sesamoid
cartilage, nasal bone, mis, adipose , frontal process of the maxilla and
fibrofatty .
Fig. 21 shows a medial dissection of a nose, imately several
millimeters from a al plane, amongst other things showing the septum cartilage
and medial crus of greater alar cartilage.
Fig. 2] shows a front view of the bones of a skull including the frontal,
nasal and zygomatic bones. Nasal concha are indicated, as are the maxilla, and
Fig. 2K shows a lateral view of a skull with the outline of the surface of a
head, as well as several muscles. The following bones are shown: l, sphenoid,
nasal, zygomatic, a, mandible, parietal, temporal and occipital. The mental
protuberance is indicated. The following muscles are shown: digastricus, masseter,
sternocleidomastoid and trapezius.
Fig. 2L shows an anterolateral view of a nose.
4.3 T INTERFACE
Fig. 3A shows a patient interface in the form of a nasal mask in
accordance with one form of the present technology.
Fig. 3B shows a schematic of a cross—section through a ure at a
point. An outward normal at the point is indicated. The curvature at the point has a
positive sign, and a relatively large magnitude when compared to the magnitude of the
curvature shown in Fig. 3C.
Fig. 3C shows a schematic of a cross—section through a structure at a
point. An outward normal at the point is indicated. The curvature at the point has a
positive sign, and a relatively small magnitude when compared to the magnitude of
the curvature shown in Fig. 3B.
Fig. 3D shows a schematic of a cross—section h a structure at a
point. An outward normal at the point is indicated. The curvature at the point has a
value of zero.
Fig. 3E shows a schematic of a cross—section through a structure at a
point. An outward normal at the point is indicated. The curvature at the point has a
negative sign, and a relatively small magnitude when compared to the magnitude of
the curvature shown in Fig. 3F.
Fig. 3F shows a schematic of a section through a structure at a point.
An outward normal at the point is indicated. The curvature at the point has a negative
sign, and a vely large ude when compared to the magnitude of the
curvature shown in Fig. 3E.
Fig. 3G shows a cushion for a mask that es two pillows. An exterior
surface of the n is indicated. An edge of the surface is indicated. Dome and
saddle regions are indicated.
Fig. 3H shows a cushion for a mask. An exterior surface of the cushion is
indicated. An edge of the surface is indicated. A path on the surface between points A
and B is indicated. A straight line distance between A and B is indicated. Two saddle
regions and a dome region are indicated.
Fig. 31 shows the surface of a structure, with a one dimensional hole in the
e. Plane curve 301D forms the boundary of a one dimensional hole.
Fig. 3] shows a cross—section through the ure of Fig.31. Surface
302D that bounds a two dimensional hole in the ure of Fig. 31 is indicated.
[01 l 1] Fig. 3K shows a perspective View of the structure of Fig. 31, including the
two dimensional hole and the one dimensional hole. Surface 302D that bounds a two
dimensional hole in the structure of Fig. 31 is indicated.
Fig. 3L shows a mask haVing an inflatable r as a cushion.
Fig. 3M shows a cross—section h the mask of Fig. 3L, and shows the
inside surface of the bladder.
Fig. 3N illustrates a left—hand rule.
Fig. 30 illustrates a right—hand rule.
Fig. 3P shows a left ear, including a left ear helix.
Fig. 3Q shows a right ear, including a right ear helix.
Fig. 3R shows a right—hand helix.
Fig. 38 shows a View of a mask, including the sign of the torsion of the
space curve defined by the edge of the g membrane in different regions of the
mask.
Fig. 4 is a perspective View of a patient interface shown on a patient’s
head ing to an example of the present technology.
Fig. 5 is a side View of the patient interface shown in Fig. 4.
Fig. 6 is a ctive view of a patient interface according to an example
of the present technology, the patient interface being shown with the headgear
removed and arm covers for upper arms of the frame assembly removed.
Fig. 7 is a front view of the patient interface shown in Fig. 6.
Fig. 8 is a rear view of the t interface shown in Fig. 6.
Fig. 9 is a side view of the patient interface shown in Fig. 6.
Fig. 10 is an exploded view of a t interface according to an example
of the t technology showing the n assembly, frame assembly, arm covers,
and elbow assembly.
Fig. 11 is an exploded view of a patient interface according to an example
of the present technology g the cushion assembly and frame assembly
removably connected with the elbow assembly removed.
Fig. 12 is an exploded view of a patient interface according to an example
of the present technology showing the frame assembly and elbow assembly
removably connected with the cushion assembly removed.
Fig. 13 is a sectional view of a patient interface according to an
example of the present logy.
Fig. 14 is an enlarged view of the patient interface shown in Fig. 13.
Fig. 15 is a front exploded view of a cushion assembly according to an
example of the present technology.
Fig. 16 is a rear exploded view of the cushion assembly shown in Fig. 15.
Fig. 17 is a front view of the cushion assembly shown in Fig. 15.
Fig. 18 is a front perspective view of a frame assembly according to an
example of the present logy.
Fig. 19 is a rear perspective view of the frame assembly shown in Fig. 18.
Fig. 20 is a side view of the frame assembly shown in Fig. 18.
Fig. 21 is a rear view of the frame assembly shown in Fig. 18.
Fig. 22 is a front view of the frame assembly shown in Fig. 18.
Fig. 23 is a cross—sectional view of the frame assembly shown in Fig. 21.
Fig. 24 is a front exploded view of the frame assembly shown in Fig. 18.
Fig. 25 is a rear exploded view of the frame assembly shown in Fig. 18.
Fig. 26 is a cross—sectional view of the frame assembly shown in Fig. 22.
Fig. 27 is a top view of an elbow assembly according to an example of the
present technology.
Fig. 28 is a perspective view of the elbow assembly shown in Fig. 27.
Fig. 29 is a side view of a patient interface shown on a patient’s head
according to an example of the present technology.
Fig. 30 is a perspective view of a t ace according to an
example of the present technology, the patient interface being shown with the
headgear removed.
Fig. 31 is a front view of the patient interface shown in Fig. 30.
Fig. 32 is a rear view of the patient interface shown in Fig. 30.
Fig. 33 is a side view of the patient ace shown in Fig. 30.
Fig. 34 is an exploded view of a patient interface according to an example
of the present logy showing the n assembly, frame assembly, and elbow
assembly.
Fig. 35 is an ed view of a patient interface according to an example
of the present technology showing the cushion ly and frame assembly
removably connected with the elbow assembly removed.
2016/050891
Fig. 36 is an exploded view of a patient interface according to an example
of the present logy showing the frame assembly and elbow assembly
removably connected with the cushion assembly d.
Fig. 37 is a cross—sectional view of a patient interface according to an
example of the present technology.
Fig. 38 is an enlarged view of the patient interface shown in Fig. 37.
Fig. 39 is a front exploded view of a cushion assembly according to an
example of the present logy.
Fig. 40 is a rear exploded view of the cushion assembly shown in Fig. 39.
Fig. 41 is a front view of the cushion ly shown in Fig. 39.
Fig. 42 is a front perspective view of a frame assembly according to an
example of the present technology.
Fig. 43 is a rear perspective view of the frame assembly shown in Fig. 42.
Fig. 44 is a side view of the frame assembly shown in Fig. 42.
Fig. 45 is a rear view of the frame assembly shown in Fig. 42.
Fig. 46 is a front view of the frame assembly shown in Fig. 42.
Fig. 47 is a sectional view of the frame assembly shown in Fig. 46.
Fig. 48 is a front exploded view of the frame assembly shown in Fig. 42.
Fig. 49 is a rear exploded view of the frame assembly shown in Fig. 42.
Fig. 50 is a perspective view of an elbow assembly ing to an
example of the present technology.
Fig. 51 is an exploded view of the elbow assembly shown in Fig. 50.
Fig. 52 is a perspective view of an elbow assembly according to an
example of the present technology.
2016/050891
Fig. 53 is an exploded view of the elbow ly shown in Fig. 52.
Figs. 54A, 54B, and 54C are rear views of small, medium, and large
cushion assemblies according to an example of the present technology.
Fig. 55 is an exploded view of a patient interface according to an
alternative example of the present technology.
Fig. 56 is a sectional view of the patient interface shown in Fig. 55.
Fig. 57 is a top view of an elbow ly according to an alternative
example of the present technology.
Fig. 58 is a cross—sectional view showing the elbow assembly of Fig. 57
attached to a patient interface according to an example of the present technology.
Fig. 59 is a ctive view of a patient interface shown on a patient’s
head according to an example of the present technology.
Fig. 60 is a side view of the patient interface shown in Fig. 59.
Fig. 61 is a perspective view of a patient interface according to an
e of the present technology, the patient interface being shown with headgear
removed.
Fig. 62 is a perspective view of the patient interface shown in Fig. 61 with
arm covers for upper arms of the frame assembly removed.
Fig. 63 is a front view of the patient interface shown in Fig. 62.
Fig. 64 is a rear view of the patient interface shown in Fig. 62.
Fig. 65 is a side view of the patient interface shown in Fig. 62.
Fig. 66 is an ed view of the patient interface shown in Fig. 61
showing the cushion assembly, frame assembly, arm covers, and elbow assembly.
2016/050891
Fig. 67 is an exploded view of the patient interface shown in Fig. 62
showing the cushion assembly and frame assembly removably connected with the
elbow assembly removed.
Fig. 68 is an exploded view of a patient interface shown in Fig. 62
showing the frame assembly and elbow ly removably connected with the
cushion assembly d.
Fig. 69 is a cross—sectional view of the patient interface shown in Fig. 63.
Fig. 70 is an enlarged view of the patient interface shown in Fig. 69.
Fig. 71 is a cross—sectional view of the patient interface shown in Fig. 65.
Fig. 72 is an ed view of the patient interface shown in Fig. 71.
Fig. 73 is a front exploded view of a cushion assembly according to an
example of the t technology.
Fig. 74 is a rear exploded view of the cushion assembly shown in Fig. 73.
Fig. 75 is a front perspective view of a frame assembly according to an
example of the present technology.
Fig. 76 is a rear perspective view of the frame assembly shown in Fig. 75.
Fig. 77 is a side view of the frame assembly shown in Fig. 75.
Fig. 78 is a front view of the frame assembly shown in Fig. 75.
Fig. 79 is a rear view of the frame assembly shown in Fig. 75.
Fig. 80 is a cross—sectional view of the frame assembly shown in Fig. 78.
Fig. 81 is a front exploded view of the frame assembly shown in Fig. 75.
Fig. 82 is a rear exploded view of the frame assembly shown in Fig. 75.
Fig. 83 a front ctive view of a shroud for a frame assembly
according to an example of the present technology.
Fig. 84 is a rear perspective View of the shroud shown in Fig. 83.
Fig. 85 is a front View of the shroud shown in Fig. 83.
Fig. 86 is a rear View of the shroud shown in Fig. 83.
Fig. 87 is front View of an upper anchor or upper arm connector for a
shroud according to an example of the present logy.
Fig. 88 is an enlarged View of the shroud shown in Fig. 84.
Fig. 89A is a front View of a shroud for a frame assembly according to
another example of the present technology.
Fig. 89B is a rear View of a shroud for a frame ly according to
another example of the present technology.
Fig. 90 is an exploded View showing connection of a lower headgear
connector arm to the shroud of a frame assembly according to an example of the
present technology.
Fig. 91 is a cross—sectional View showing connection of a lower headgear
connector arm to the shroud of a frame assembly according to an example of the
present technology.
Fig. 92 is a front View of a frame assembly ing to r example
of the present technology.
Figs. 93 and 94 are exploded Views of lower headgear connector arms for
the frame assembly of Fig. 92.
Fig. 95 is a rear perspective View of a lower headgear connector arm for
the frame assembly of Fig. 92.
Fig. 96 shows a manufacturing process for a lower ar connector
arm ing to an example of the present technology.
Fig. 97 shows a manufacturing process for a lower headgear connector
arm according to another example of the present technology.
Fig. 98 is an ed view showing connection of a lower ar
connector arm to the shroud of a frame assembly according to another example of the
present technology.
Fig. 99 is an exploded view showing connection of an upper headgear
connector arm to the shroud of a frame assembly according to an example of the
present technology.
Fig. 100 is a cross—sectional view showing connection of an upper
headgear connector arm to the shroud of a frame assembly according to an example of
the present technology.
Fig. 101 is a front perspective view of a headgear clip according to an
example of the t technology.
Fig. 102 is a rear ctive view of the headgear clip shown in Fig. 101.
Fig. 103 is a cross—sectional view showing connection of the headgear clip
of Fig. 101 to the lower headgear connector arm of a frame assembly according to an
example of the present technology.
Fig. 104 is a cross—sectional view showing connection of an upper side
strap of headgear to the upper headgear connection point of a frame assembly
according to an example of the present logy.
DETAILED PTION OF EXAMPLES OF THE
TECHNOLOGY
Before the present technology is described in further detail, it is to be
understood that the technology is not d to the particular examples described
herein, which may vary. It is also to be understood that the terminology used in this
disclosure is for the purpose of describing only the particular examples discussed
herein, and is not ed to be limiting.
The following description is provided in relation to various examples
which may share one or more common teristics and/or features. It is to be
understood that one or more features of any one e may be combinable with one
or more features of r example or other es. In addition, any single
feature or combination of features in any of the examples may constitute a further
.1 THERAPY
In one form, the present technology comprises a method for ng a
respiratory disorder comprising the step of applying positive pressure to the entrance
of the s of a patient 1000.
In certain examples of the present technology, a supply of air at positive
pressure is provided to the nasal passages of the patient via one or both nares.
In certain examples of the present logy, mouth breathing is limited,
restricted or prevented.
.2 TREATMENT SYSTEMS
In one form, the present technology comprises an apparatus or device for
treating a respiratory disorder. The apparatus or device may comprise an RPT device
4000 for supplying pressurised air to the patient 1000 via an air circuit 4170 to a
patient interface 3000, e.g., see Figs. 1A to 1C.
.3 PATIENT INTERFACE
A vasive patient interface 3000 in accordance with one aspect of
the present technology comprises the following functional aspects: a seal—forming
structure 3100, a plenum chamber 3200, a positioning and stabilising structure 3300, a
vent 3400, one form of connection port 3600 for tion to air circuit 4170, and a
ad support 3700. In some forms a functional aspect may be provided by one or
more physical components. In some forms, one physical component may provide one
or more functional aspects. In use the seal—forming structure 3100 is arranged to
surround an entrance to the s of the patient so as to facilitate the supply of air at
positive pressure to the airways.
Figs. 4 to 28 show a non—invasive patient interface 6000 in accordance with
one aspect of the present technology comprising a frame assembly 6100, a cushion
ly 6175 including a orming structure 6200, an air delivery connector
(e.g., elbow assembly 6600), and a positioning and stabilising structure (e.g., headgear
6800). Figs. 4 and 5 are exemplary views of the patient interface 6000 on a patient’s
head (with arm covers 6750 for upper arms 6134 of the frame assembly 6100
attached), and Figs. 6 to 10 are exemplary views of the patient interface 6000 with the
headgear 6800 and the arm covers 6750 removed. In use, one form of the seal—
forming ure 6200 is ed to surround an ce to the airways of the
patient 1000 so as to facilitate the supply of air at positive pressure to the airways.
The seal—forming structure 6200 (e.g., constructed of silicone) may also be commonly
referred to as a cushion. In some forms, a functional aspect may be provided by one
or more physical components. In some forms, one al ent may provide
one or more functional aspects.
In one form of the present technology, the frame assembly 6100 connects as
an ediate component to the cushion assembly 6175 and the elbow assembly
6600. That is, the cushion assembly 6175 connects to the frame assembly 6100 (via a
first retention feature on the frame ly) independently of the elbow assembly
6600 (see Fig. 11), and the elbow assembly 6600 connects to the frame assembly
6100 (via a second retention feature on the frame assembly) independently of the
cushion ly 6175 (see Fig. 12). However, the seal for the air flow path is
formed between the elbow assembly 6600 and the cushion assembly 6175, i.e., the
frame assembly 6100 is not in the air flow path (e.g., see Figs. 13 and 14).
Alternatively, a first seal for the air flow path may be formed between the elbow
assembly 6600 and the frame assembly 6100, while a separate second seal may be
formed between the frame ly 6100 and the cushion assembly 6175. In this
instance, the frame assembly 6100 may remain in the air flow path. The retention
connections of the cushion assembly 6175 and the elbow assembly 6600 to the frame
assembly 6100 are separate and distinct from one another and allow independent
engagement/disengagement, e.g., such that the frame assembly 6100 may remain
connected to either of the cushion assembly 6175 or elbow assembly 6600 when
disconnecting either of these components. For example, this arrangement allows the
cushion assembly 6175 to be disconnected from the frame assembly 6100 (e.g., to
change n sizes) while maintaining tion between the frame assembly
6100 and the elbow assembly 6600, yet maintaining the ability to disconnect the
elbow assembly 6600 from the frame assembly 6100.
In the illustrated e, the seal—forming structure 6200 of the patient
interface 6000 of the present technology may be held in sealing position in use by the
headgear 6800. As illustrated in Figs. 4 and 5, the headgear 6800 es a pair of
upper side straps 6802 and a pair of lower side straps 6804 connected to a circular
crown strap 6806 that encapsulates the crown of the patient’s head. The upper side
straps 6802 connect to the upper headgear connector 6130 of the frame assembly
6100 and the lower side straps 6804 connect to the lower headgear connector 6150 of
the frame assembly 6100, e.g., via ar clips 6160. The side straps 6802, 6804
may include an adjustable hook and loop oTM) connection mechanism, e.g.,
VelcroTM—like hook tabs, to facilitate tion and/or adjustment.
Figs. 59 to 100 show a patient interface 16000 according to another example
of the present technology. The patient interface includes a frame assembly 16100, a
cushion ly 16175 including a seal—forming structure 16200, an air delivery
connector (e.g., elbow assembly 16600), and a positioning and ising structure
(e.g., headgear 16800 including upper side straps 16802, lower side straps 16804, and
crown strap 16806). Figs. 59 to 61 are exemplary views of the patient interface 16000
with arm covers 16750 for upper arms 16134 of the frame assembly 16100 attached,
and Figs. 62 to 68 are exemplary views of the patient interface 16000 with the
headgear 16800 and the arm covers 16750 d.
Similar to the example described above, the cushion assembly 16175 connects
to the frame assembly 16100 (via a first retention feature on the frame assembly)
independently of the elbow assembly 16600 (see Fig. 67), and the elbow assembly
16600 ts to the frame assembly 16100 (via a second ion feature on the
frame assembly) independently of the cushion assembly 16175 (see Fig. 68). That is,
the retention connections of the cushion assembly 16175 and the elbow assembly
16600 to the frame assembly 16100 are separate and distinct from one another and
allow independent engagement/disengagement.
In the example of patient interface 16000, a first seal for the air flow path is
formed between the elbow assembly 16600 and the frame assembly 16100, and a
separate second seal is formed between the frame assembly 16100 and the cushion
assembly 16175. In this example, the frame assembly 16100 is provided in the air
flow path. That is, the elbow assembly 16600 is ured to ish a hard—to—hard
connection and c seal with the frame assembly 16100, and the cushion
assembly 16175 is structured to establish a separate hard—to—hard connection and static
seal with the frame assembly 16100.
Also, in the e of patient interface 16000, the frame assembly 16100
includes a lockout feature along the opening 16105 that is structured and arranged to
prevent direct connection or insertion of the air circuit 4170, e.g., air delivery tube.
This arrangement requires use of the elbow assembly 16600 to interconnect the frame
assembly 16100 and the air circuit 4170, thereby ensuring that the elbow assembly
16600 (and its vent and sphyxia valve (AAV)) are present in the system.
In the example shown in Figs. 4 to 28 and 59—100, the patient interface is a
full—face/oro—nasal interface type ing a seal—forming structure 6200 structured to
form a seal around the patient’s nose and mouth. However, aspects of the present
technology may be d for use with other suitable interface types, e.g., nasal
interface, nasal prongs.
For example, Figs. 29 to 54C show a non—invasive t interface 7000 in
accordance with another aspect of the present technology. In this example, the patient
ace is a nasal interface type including a seal—forming structure 7200 ured to
form a seal around the patient’s nose. The patient interface 7000 comprises a frame
assembly 7100, a cushion assembly 7175 including the seal—forming structure 7200,
an elbow ly 7600, and a positioning and stabilising structure (e.g., headgear
7800). Similar to the above, the cushion assembly 7175 connects to the frame
assembly 7100 ndently of the elbow assembly 7600 (e.g., see Fig. 35), and the
elbow assembly 7600 ts to the frame assembly 7100 independently of the
cushion assembly 7175 (e.g., see Fig. 36). In this example, the seal for the air flow
path is formed between the elbow assembly 7600 and the cushion assembly 7175
(e.g., see Figs. 37 and 38).
Frame Assembly
As best shown in Figs. 18 to 26, the frame assembly 6100 includes a shroud or
wall member 6110, an upper ar connector 6130 provided to an upper portion of
the shroud 6110, and a lower headgear connector 6150 provided to a lower portion of
the shroud 61 10. The frame assembly 6100 provides a connection between the
n assembly 6175 and the elbow assembly 6600, and also provides a connection
between the cushion assembly 6175 and the headgear 6800, e.g., either in a removable
fashion or a more permanent fashion, to allow sealing forces to be transferred to the
cushion ly 6175 from the headgear 6800. In the illustrated example, upper and
lower headgear connectors 6130, 6150 provide a 4—point connection to the ar
6800.
The shroud 6110 (e.g., ucted of a relatively hard plastic al such as
polycarbonate) includes an opening 6105 through which the elbow assembly 6600
sealingly engages with the cushion assembly 6175 (e.g., see Figs. 13 and 14).
In the illustrated example, the opening 6105 is bounded by an annular flange
6115 that protrudes forwardly from an anterior or front side of the shroud 6110. The
flange 6115 includes a rim 6117 along its free end which defines a circular channel
6120 ured to interface with the elbow assembly 6600.
The posterior or rear side of the shroud 6110 includes a plurality of spring
arms 6125 (e.g., 3, 4, 5, or more spring arms) spaced around the opening 6105. Each
of the spring arms 6125 includes a barbed end structured to provide a mechanical
interlock, e. g., snap—fit connection, with the cushion assembly 6175.
In an alternative example, as best shown in Figs. 75 to 100, the frame
assembly 16100 includes a shroud or wall member 16110, a pair (i.e., right and left)
of upper headgear connector arms 16134 (each comprising two flexible portions
16140, 16145) extending from respective sides of an upper portion of the shroud
16110, and a pair (i.e., right and left) of lower headgear connector arms 16154
ing from respective sides of a lower portion of the shroud 16110.
In the illustrated example, the opening 16105 of the shroud 16110 (e.g.,
constructed of a relatively hard plastic material such as polycarbonate) is bounded by
an outer annular flange 16115 and an inner r flange 16125.
The outer annular flange 16115 protrudes forwardly from an anterior or front
side of the shroud 16110. The flange 16115 includes a rim 16117 along its free end
which s a circular channel 16120 ured to interface with the elbow
assembly 16600.
The inner annular flange 16125 protrudes rearwardly from a posterior or rear
side of the shroud 16110. The flange 16125 includes a ity of tabs or s
16127 along its perimeter (e.g., see Figs. 70, 76, 84, 86, and 88), e.g., 2, 3, 4 or more
tabs, which are structured to provide a mechanical interlock, e.g., snap—fit tion,
with the cushion assembly 16175 so as to releasably connect the frame assembly
16100 to the cushion assembly 16175. In the illustrated example, the tabs 16127 are
ed on superior and inferior sides of the flange (i.e., north and south sides),
however alternative arrangements are possible, e.g., tabs provided on anterior and
posterior sides of the flange (i.e., east and west sides).
In on, a radially inwardly extending ridge 16400 protrudes from the
flange 16125 into the opening 16105. As described in more detail below, the ridge
16400 acts as a stop to prevent over—insertion of the elbow assembly 16600 into the
frame ly 16100. Also, the ridge 16400 provides a dynamic face seal with the
elbow ly 16600.
Also, the ridge 16400 includes a plurality of projections 16405 along its
perimeter (e.g., 2, 3, 4, or more projections), which are structured to provide a t
feature along the g 16105 to t direct connection or insertion of the air
t 4170, e.g., air delivery tube, to the frame assembly 16100. This arrangement
ensures that the elbow assembly 16600 (and its vent and anti—asphyxia valve (AAV))
is used to interconnect the frame assembly 16100 and the air circuit 4170.
In the illustrated example, the plurality of projections 16405 are structured and
arranged to have minimal or no impact on noise (from flow through the opening
16105), impedance to air delivery (inlet flow to the patient), and C02 washout (outlet
flow to the vent of the elbow assembly 16100).
In the nasal interface example, e.g., see Figs. 42 to 49, the frame assembly
7100 includes a shroud 7110 and a headgear connector 7130 provided to the shroud
7110 to provide a 4—point connection to the headgear 7800. The shroud 7110 (e.g.,
constructed of a relatively hard plastic material such as polycarbonate) includes an
opening 7105 providing an annular edge structured to engage with the elbow
assembly 7600. The posterior or rear side of the shroud 7110 includes a plurality of
locking tabs or spring arms 7125 (e.g., 2, 3, 4, 5, or more tabs or spring arms) spaced
around the g 7105 and structured to provide a mechanical interlock, e.g., snap—
fit connection, with the n assembly 7175.
Upper and Lower Headgear tors
The upper headgear connector 6130 includes a shroud connection portion
6132 provided to an upper portion of the shroud 6110 and a pair (i.e., right and left) of
rigidised upper headgear connector arms 6134 (each comprising two flexible portions
6140, 6145) extending from respective sides of the shroud connection portion 6132
and structured to connect to respective upper headgear straps of the headgear. The
lower headgear connector 6150 includes a shroud connection portion 6152 provided
to a lower n of the shroud 6110 and a pair (i.e., right and left) of lower headgear
connector arms 6154 extending from respective sides of the shroud connection
portion 6152 and structured to connect to respective lower headgear straps of the
headgear.
In the illustrated example, each upper headgear connector arm 6134 includes
an upper headgear connection point in the form of a slot 6135 structured to receive a
respective upper headgear strap 6802 of the headgear. In the illustrated example, each
lower headgear tor arm 6154 includes a lower headgear connection point in the
form of a magnetic connector 6155 structured to locate and t to a magnet 6162
associated With a headgear clip 6160 provided to a respective lower headgear strap
6804 of the ar. r, it should be appreciated that the upper and lower
headgear connector arms 6134, 6154 may be connected With headgear straps of the
headgear in other suitable manners.
Each of the upper headgear connector arms 6134 is structurally rigid to resist
torsion (twisting) and each includes central and eral flexible portions 6140,
6145 to conform to varying facial es. The central flexible portion 6140 of each
arm 6134 is positioned proximal to the shroud 6110 and the shroud connection
portion 6132. The peripheral flexible portion 6145 of each arm 6134 is positioned
between the upper headgear connection point 6135 and the central flexible portion
6140. The central e portion 6140 is separated from the eral flexible
portion 6145 by a first rigid portion 6143. The peripheral flexible portion 6145 is
2016/050891
separated from the upper headgear connection point 6135 by a second rigid n
6147.
Each upper arm 6134 extends and curves in an upwards direction between the
eyes and ears to avoid obstructing patient’s vision, position the headgear attachment
point (e. g., slot 6135) so that the upper headgear straps extend above and avoid the
t’s ears, and provide a force vector that extends generally parallel to the
Frankfort horizontal line (e.g., see Figs. 4 and 5).
The upper arms 6134 are also curved (orthogonal to the plane of the face) to
conform to the facial profile e.g., the arms curve to lly match the curvature of
the cheek bones and avoid load on the temple.
The upper arms 6134 are rigidised to resist deformation in order to maintain
its predetermined shape to ensure the frame assembly 6100 positions the headgear
attachment points in the same on and avoid translating ar n forces
to compressive forces resulting in uncomfortable facial contact by the upper arms.
The upper arms 6134 are also sed to resist tension forces that may be
provided by the headgear straps to prevent twisting of the arms.
In an example, the upper arms are rigidised or stiffened such that that they
maintain a preformed 3D shape (not floppy) structured to conform to the facial profile
and positions the headgear ment points in the appropriate locations. Each upper
arm maintains its preformed shape due to its rigidity or stiffness in particular
orientations. The upper arms are structured to be less resistant (less stiff or rigid) to
bending into and away from the face to adapt g facial widths. The upper arms
are rigidised such that they do not substantially deform under tension forces applied
by the headgear straps, thereby acting as an intermediary between the headgear straps
and the cushion assembly to convert the tension forces from the headgear straps to a
compressive force applied on the seal—forming structure to provide seal and stability
on the face. The upper arms are also shaped to apply the appropriate force vectors on
the seal—forming structure via the shell to effect a stable and comfortable seal. In an
example, the seal—forming structure is pulled into the face under the appropriate
compressive force that is also in line with the Frankfort ntal plane (that is pulled
directly back into the face).
In an example, the upper arms are rigidised to provide torsional rigidity to be
resistant to deformation under twisting. The upper arms are also resistant to bending
ation vertically up and down alongside the face (i.e., remain at the correct
height above the ears. However, the upper arms are also structured to provide a
predetermined level of deformation to allow bending (allows bending towards/away
from the face) to adjust for varying facial width. In on, the upper arms are
resilient/elastic in this orientation to allow the upper arms to return to their original
positions. This feature may also prevent discomfort by minimising the load/force
d by the frame assembly on the face when the headgear straps are tightened by
absorbing some of these tension forces due to its flexibility. In some locations, the
upper arms may also provide substantially rigidity/stiffness to avoid contact of the
face, wherein the arms may act as a strut to resist bending deformation or
compression into the face from ar tension. Conversely, in other locations, the
flexibility of the arms may allow the arms to collapse under tension or compression
from side load (e.g., when a patient sleeps on their side, thereby ng a side load
on the patient interface. The arms absorb the compressive force applied by the side
load and prevent it from dislodging the seal—forming structure. This flexibility also
allows for better conformation to the face, which increases comfort and also ts
seal instability from side load.
The l flexible n 6140 is configured to allow the respective arm
6134 to flex to adapt to varying facial width (between patients). For example, for
wide faces, the central flexible n 6140 allows the arms 6134 to flex outwardly
away from one another and away from the face, and for narrow faces, the central
flexible portion 6140 allows the arms 6134 to flex towards one another and s
the face. In the rated example, the central flexible portion 6140 of each arm
comprises a single slot 6141 (on an anterior side) forming a hinge.
It should be appreciated that the slot 6141 may include other suitable
arrangements and configurations to modify the location and flexibility characteristics
of the arm, e.g., more than one slot, slots on one or both sides of the arm (anterior
and/or posterior sides), g between slots, width, depth, orientation or angle of
slot on the arm. In an example, the slot 6141 may be filled with a flexible material.
In alternative es, the hinge may be provided by a number of different methods,
e. g., such as a thinner cross section or the use of a flexible material joint.
The first and second rigid portions 6143, 6147 provide structural rigidity to the
arms 6134 to support its predetermined shape.
The eral flexible portion 6145 is configured to allow the respective arm
6134 to conform to the varying curvature or profile of the user’s face, e.g., conform to
cheek ion between patients. For e, the eral flexible portion 6145
articulates to conform to the width and profile of the cheeks above the cheek bones of
the user. In the illustrated example, the peripheral flexible portion 6145 of each arm
6134 comprises a plurality of slots 6146 (on each side of the arm, i.e., slots on anterior
and posterior sides of the arm) forming a plurality of hinges over the cheek region.
The hinges allow the arms 6134 to articulate and conform to micro variations of the
cheek region and distribute load on the face more evenly upon headgear tension, e.g.,
when compared to a rigidiser arm without any flex.
In the illustrated example, the slots 6146 are generally parallel to one another,
generally evenly spaced apart from one r, and include similar widths and
depths into the thickness of the arm. However, it should be appreciated that the slots
6146 may include other suitable ements and configurations to modify the
location and lity characteristics of the arm 6134, e.g., number of slots, slots on
one or both sides of the arm (anterior and/or posterior sides), spacing between slots,
width, depth, orientation or angle of slot on the arm (e.g., slots angled relative to one
another to e bending in different orientations). In an example, one or more of
the slots 6146 may be filled with a flexible material. In an alternative example, the
hinge may be provided by a ity of flexible sections (by material) spaced apart by
rigid segments.
In alternative examples, it should be iated that the upper headgear
connector arms 6134 may include any suitable number of flexible portions along its
length to modify its flexibility characteristics, e.g., one, two, three or more flexible
portions.
In the illustrated example, to minimise discomfort, the upper arms 6134 may
have a smooth and curved surface profile to distribute load and allow the arms rock
over the face without a concentrated load or stabbing into the face. For example, as
shown in Fig. 26, each upper arm 6134 may include a generally lozenge—shaped cross—
section, e. g., generally flat but slightly dome shape on either side to increase contact
comfort.
In an example, the lower headgear connector arms 6154 are relatively more
flexible than the upper headgear connector arms 6134, e.g., the lower headgear
connector arms 6154 have less resistance against torsion such that they may twist with
the lower headgear straps of the headgear. This flexibility allows the lower arms
6154 to twist and turn with the lower headgear straps to t forced disconnection
of the retention features under these forces, i.e., maintain connection of the lower
arms with the lower headgear straps.
Each lower arm 6154 comprises the magnetic connector 6155 (e.g., d
) structured to locate and connect to the headgear clip 6160 provided to the
respective lower headgear strap of the headgear. The ic connector 6155 also
provides a receptacle 6156, which allows insertion and ion of a corresponding
protrusion (e.g., provided by the magnet 6162 of the headgear clip 6160) to resist
disconnection from tension of the headgear straps. The retention allows tion to
be maintained while allowing the headgear clip 6160 to rotate relative to respective
lower arm 6154. That is, the protrusion/magnet 6162 of the ar clip 6160 and
the receptacle 6156 of the magnetic tor 6155 include corresponding cylindrical
shapes to allow ve rotation. The magnets are used for locating the headgear clip
in t position for retaining engagement via engagement of the protrusion/magnet
6162 member into the receptacle 6156.
The upper and lower arms 6134, 6154 are connected to the shroud 6110 via
the respective shroud connection portion 6132, 6152. In the illustrated example, the
upper and lower arms 6134, 6154 are permanently (e.g., co—molded, overmolded)
connected to the shroud 6110. As illustrated, each shroud connection portion 6134,
6154 includes a plurality of pins 6133, 6153 that are received in respective openings
6113, 6114 provided to the shroud 6110 which form rivets to mechanically secure the
upper and lower arms 6134, 6154 to the shroud 6110 after the g process (e.g.,
see Figs. 21, 24, and 25). In the illustrated example, the shroud 6110 includes upper
and lower grooves 6111, 6112 ured to receive respective shroud connection
portions 6132, 6152 of the upper and lower headgear connectors, and the openings
6113, 6114 for securing the upper and lower headgear connectors are provided within
the s 6111, 6112 (e.g., see Figs. 24 and 25). However, it should be appreciated
that the upper and lower headgear connector arms 6134, 6154 may be connected to
the shroud 6110 in other suitable manners, e.g., removable connection.
In an example, the upper arms 6134 and/or the lower arms 6154 may be
covered by a textile, e.g., for aesthetics, increase perception of softness/comfort. For
example, Figs. 4 and 5 show a textile arm cover or sock 6750 ed to the upper
arms 6134, while Figs. 6 to 10, for example, show the upper arms 6134 with the arm
covers 6750 removed.
The upper and lower arms may provide targeted flexibility in alternative
manners. For example, the arms may be formed by a single material with a varying
cross sectional thickness for targeted flexibility, e.g., flexible areas may be thinner to
provide a living hinge, while thickened areas will have a reduced flexibility. In
another example, the arms may be formed by two or more materials, each material
having different elastic properties/young’s modulus, e.g., rigid sections may be
formed in rigid als such as polycarbonate, while each rigid section may be
joined by an intermediary e/soft material such as liquid silicone rubber to
provide targeted flex. In another example, the arms may be formed in layers of
ent materials, e. g., the arms may be formed by at least a bendable or flexible
first layer. The flexible first layer may provide a substrate surface for multiple rigid
portions that are spaced apart to form a second rigid layer. The rigid portions may flex
relative to each other, while being supported by the first layer. In an example, the
substrate layer in this example has the required stretch properties to provide the
required n forces to the t interface. In the current example, the substrate
layer has l to no stretch to prevent the tension forces from being absorbed by
the ate layer.
The arms provide the required stiffness (e.g. resist torsional forces, maintain a
preformed shape, etc.) for ining the patient ace in the desired position.
However, the arms may in some cases provide a reduction in t due to the
hardness and rigidity of the component (i.e., resistance to conforming to the face).
This discomfort is due to a combination of tactile feel and resistance in conforming to
facial profile variations, which may provide an undesirable load on sensitive portions
of the face. To overcome this aspect, the arms may be coated or covered with a softer
and in some cases a less rigid material. The material may act to absorb some or all of
the compressive forces applied by the arms on the user’s face. Moreover, the soft
and/or less rigid material may act to m to facial profile variations, thereby
acting as a conforming layer. In on, the arm may be coated or d with a
tactile layer may have a desirable tactile feel for direct contact with the user’s face.
The tactile layer may comprise a ble fabric with enhanced tactile feel and
desirable predetermined stretch characteristics. The arm may further comprise a
compliant layer comprising a less rigid and/or soft material such as foam for
absorbing the compressive forces applied by the arm on the user’s face and/or
complying with facial variations by ming the facial profile.
In an example, both the tactile layer and the compliant layer may be structured
or comprise materials that substantially do not alter the function of the arms. That is,
the layers should not alter the preformed shape of the arms. Moreover, the layers
should allow for the arms to flex/bend in particular orientations as defined. Thus the
layers should be structured or comprise selected als to maintain the function of
the arms. Furthermore, the layers may be permanently or semi—permanently fixed to
the arms. Alternatively, the arms may comprise a removable layer to cover the arms.
For example, the removable layer may be a textile cover or sock. The arm may
comprise a or surface for contact with the user’s face. The superior surface may
comprise a foam layer above the rigid material, which is subsequently d by the
tactile layer. The arm may also comprise an inferior surface covered by the tactile
layer.
There are a number of ways to fix the layers to the arm. In one example, the
compliant layer is a foam such as memory foam, which is glued, ting, moulded,
mechanically attached, etc. to the superior surface of the arm. The tactile layer is then
attached to the foam compliant layer by laminating, stitching, gluing, etc. the tactile
layer to the foam. In an e, in both cases the attachment means should not
substantially alter the shape and ty of the arms. That is, the attachment means for
the layers should not substantially change the flexing/bending of the arms nor change
the ability of the arms to maintain its preformed shape.
In the ative example shown in Figs. 75 to 100, each upper headgear
connector arm 16134 includes a shroud connection portion 16132 provided to a
respective upper portion of the shroud 16110, and each lower headgear connector arm
16154 es a shroud connection n 16152 provided to a tive lower
portion of the shroud 16110.
In the illustrated example, each upper headgear connector arm 16134 includes
an upper headgear connection point in the form of a slot 16135 structured to receive a
respective upper headgear strap 16802 of the headgear. As best shown in Fig. 104,
the bridge or cross—bar 16136 defining the slot 16135 includes a leading edge 16136A
that is tapered (e. g., like a knife edge) to tate assembly/disassembly to the upper
headgear strap 16802 of the ar. For example, the tapered g edge 16136A
may readily slide through and between the VelcroTM—like hook tab 16803 and the
remainder of the upper headgear strap 16802 to facilitate assembly/disassembly
without fully ing the VelcroTM—like hook tab 16803 from the remainder of the
upper headgear strap 16802. In the illustrated example, each lower headgear
connector arm 16154 includes a lower headgear connection point in the form of a
magnetic connector 16155 structured to locate and connect to a magnet associated
with a headgear clip 16160 provided to a respective lower headgear strap 16804 of the
headgear. However, it should be appreciated that the upper and lower headgear
connector arms 16134, 16154 may be connected with headgear straps of the headgear
in other suitable manners.
r to the upper headgear connector arms described above, each of the
upper headgear connector arms 16134 is structurally rigid to resist torsion (twisting)
and each includes central and peripheral flexible portions 16140, 16145 to conform to
varying facial profiles. The central flexible portion 16140 (i.e., the first flexible
portion) of each arm 16134 is positioned proximal to the shroud tion portion
16132. The peripheral e portion 16145 (i.e., the second flexible portion) of
each arm 16134 is positioned between the upper headgear connection point 16135 and
the central flexible portion 16140.
In the illustrated example, the l flexible portion 16140 of each arm
16134 comprises a single slot 16141 (on a posterior side) forming a hinge. In the
illustrated e, the peripheral flexible portion 16145 of each arm 16134
2016/050891
comprises a plurality of slots 16146 (on each side of the arm, i.e., slots on anterior
and/or posterior sides of the arm) g a plurality of hinges over the cheek region.
In examples, the peripheral flexible portion 16145 of each arm need not
include slots on the anterior or posterior sides. Instead, or in addition, the flexible
portion may include one or more interconnecting meric (e.g., silicone) sections
that may form a flush or smooth transition between relatively harder plastic sections,
but allow flexing, bending and/or pivoting. These can be made via insert or over
molding, where the harder plastic ns are placed in the mold and the
interconnecting sections are molded over the harder plastic sections.
Each lower headgear connector arm 16154 comprises the magnetic tor
16155 (including encased magnet 16155B) structured to locate and connect to the
headgear clip 16160 (including d magnet 16162) provided to the respective
lower headgear strap of the headgear, e.g., see Fig. 103. In the illustrated example,
the end of each lower arm 16154 includes a magnet receiving portion 16155A to
receive and align a magnet 16155B and a cap 16155C to enclose and retain the
magnet 16155B to the magnet receiving portion 16155A. As illustrated, the magnetic
tor 16155 provides a sion which allows it to be inserted and retained
within a corresponding receptacle provided by the ar clip 16160, e.g., see Fig.
103. The headgear clip 16160 includes a catch or retaining wall 16164 that resists
disconnection from tension of the headgear straps while allowing the headgear clip
16160 to rotate (e.g., allow for 3600 rotation) relative to respective lower arm 16154.
In the illustrated example, as shown in Figs. 101, 102, and 103, the catch or ing
wall 16164 (e.g., semi—circular cross—section or U—shape) provides a mechanical
retention member to mechanically engage with a semi—circular peripheral region of
the connector 16155. In an example, the magnetic connector 16155 and/or the catch
or retaining wall 16164 may be angled or sloped to provide an undercut to facilitate
retention of the headgear clip 16160 on the magnetic connector 16155.
In an example, as shown in Fig. 96, each lower headgear connector arm 16154
and ic connector 16155 thereof may be manufactured by molding the cap
16155C, assembling the magnet 16155B in the cap 16155C, inserting the assembled
cap/magnet in a lower arm molding tool, and then g the lower arm 16154 to the
cap/magnet. In an example, the cap 16155C may include an orientation feature, e.g.,
2016/050891
slot 16159, to facilitate correct orientation and alignment of the cap 16155C relative
to the lower arm 16154.
In an alternative example, as shown in Fig. 97, each lower headgear connector
arm 16154 and magnetic connector 16155 thereof may be manufactured by molding
the lower arm 16154, assembling the magnet 16155B in the magnet receiving portion
16155A of the lower arm 16154, inserting the assembled lower arm/magnet in a cap
molding tool, and then lding the cap 16155C to the lower arm/magnet.
In the illustrated example, each lower headgear connector arm 16154
comprises a single slot 16156 (on a posterior side) forming a hinge portion, e.g., see
Figs. 75 and 76. This hinging portion is structured and arranged to accommodate for
facial width variation by allowing the lower arms 16154 to flex away from the
patient’s face in use, e. g., allows easy adjustment during initial fitting of the patient
interface and allows on to various facial geometry without affecting seal of the
patient ace. Also, the hinging portion allows the lower arms 16154 to move or
flex with corresponding headgear clips 16160 in use, e.g., to prevent inadvertent
detachment of the headgear clip 16160 from the respective ic connector 16155.
The upper and lower arms 16134, 16154 are connected to the shroud 16110
via the respective shroud connection portion 16132, 16152. In the illustrated
e, the upper and lower arms 16134, 16154 are ently ted (e.g.,
ultrasonically welded) to the shroud 16110.
As shown in Figs. 83 to 86, the shroud 16110 includes a pair (i.e., right and
left) of upper anchors or upper arm connectors 16450 on respective sides of an upper
n of the shroud 16110, and a pair (i.e., right and left) of lower anchors or lower
arm connectors 16460 on respective sides of a lower portion of the shroud 16110.
Each upper anchor 16450 provides an opening 16452 and each lower anchor 16460
provides an opening 16462.
As shown in Figs. 90 and 91, the shroud connection portion 16152 of each
lower arm 16154 includes a protrusion 16153 that is received in the opening 16462 of
a respective lower anchor 16460. The protrusion 16153 includes an opening 16153A
that receives a protrusion 16158 provided to a cap 16157 which engages and
interlocks the shroud tion portion 16152 to the cap 16157. The shroud
connection n 16152 and the cap 16157 are ultrasonically welded to
mechanically secure the shroud connection portion 16152 to the cap 16157, thereby
securing the lower arm 16154 to the lower anchor 16460.
In the illustrated example, the caps 16157 are symmetrical to tate
manufacturing and assembly. However, it should be appreciated that the caps for
secruing the lower arms may be assymetrical. For example, Figs. 92 to 95 show an
alternative arrangement in which lower arms 17154 are secured to the shroud 17110
with respective asymmetrical caps 17157.
Similarly, as shown in Figs. 99 and 100, the shroud connection portion 16132
of each upper arm 16134 includes a sion 16133 that is received in the g
16452 of a respective upper anchor 16450. The sion 16133 includes an opening
16133A that receives a protrusion 16138 provided to a cap 16137 which engages and
interlocks the shroud connection portion 16132 to the cap 16137. The shroud
connection portion 16132 and the cap 16137 are ultrasonically welded to
mechanically secure the shroud connection portion 16132 to the cap 16137, thereby
securing the upper arm 16134 to the upper anchor 16450
However, it should be appreciated that the upper and lower headgear
connector arms 16134, 16154 may be connected to the shroud 16110 in other suitable
manners, e.g., removable connection. For example, Fig. 98 illustrates a connector
arm 17134 connected to an anchor 17450 via a snap joint, e.g., push h snap
joint arrangement including pegs structured to engage within respective openings with
a snap fit.
In an example, the upper and/or lower anchors 16450, 16460 of the shroud
16110 may be structured to enhance robustness. For example, the sharp s along
the anchor may be eliminated to reduce stress tration, e.g., edges along the
opening of the anchor may be rounded (e.g., see Fig. 87). Also, the bridge member of
the anchor may be provided with an increased thickness to increase n strength,
e. g., see bridge member 16454 of upper anchor 16450 in Fig. 87. In addition, ribs
may be provided to arms of the anchor to increase strength, e.g., see ribs 16456
provided to arms of upper anchor 16450 in Fig. 87.
In an example, the upper arms 16134 and/or the lower arms 16154 may be
covered by a e, e.g., for tics, increase perception of softness/comfort,
provide comfort on the face and se marking. For example, Figs. 59 to 61 show
a textile arm cover or sock 16750 provided to the upper arms 16134, while Figs. 62 to
65, for example, show the upper arms 16134 with the arm covers 16750 removed.
The cover 16750 conceals the upper arms 16134 making the outer surface smooth to
increase comfort on the face, e.g., no marking and easier to slide over the facial
surface. The cover 16750 may be optionally removable.
In an example, at least a portion of the upper arms 16134 and/or the lower
arms 16154 may include dimples or a gold ball pattern, e.g., for aesthetics.
In the nasal interface example, e.g., see Figs. 42 to 49, the headgear tor
7130 includes a shroud connection portion 7132 ted to the shroud 7110, a pair
(i.e., right and left) of upper headgear connector arms 7134 structured to connect to
respective upper headgear straps 7802 of the headgear 7800, a pair (i.e., right and left)
of lower headgear connector arms 7154 structured to connect to respective lower
headgear straps 7804 of the headgear 7800, and intermediate portions 7133 to
interconnect the upper and lower arms 7134, 7154 with the shroud connection n
7132.
In the illustrated example, each upper headgear connector arm 7134 includes
an upper headgear connection point in the form of a slot 7135 ured to receive a
respective upper headgear strap 7802 of the headgear 7800 (see Fig. 29). In the
illustrated example, each lower headgear tor arm 7154 es a lower
headgear connection point in the form of a magnetic connector 7155 structured to
locate and connect to a magnet associated with a headgear clip 7160 provided to a
respective lower headgear strap 7804 of the headgear 7800 (see Fig. 29). However, it
should be appreciated that the upper and lower headgear tor arms 7134, 7154
may be connected with headgear straps of the headgear in other suitable manners.
Similar to the above example, each intermediate portion 7133 of the headgear
connector 7130 assembly includes a flexible portion 7140 to conform to varying facial
profiles, e. g., accommodate facial width variations. In the illustrated example, the
flexible portion 7140 comprises a single slot (on or and/or posterior sides)
forming a hinging section nt the cushion assembly.
As shown in Figs. 48 and 49, the headgear connector 7130 may include a
layered configuration, e.g., layers of different als to provided desired
flexibility.
Cushion Assembly
In one form of the present technology, the cushion assembly or cushion
module 6175 includes a main body, s, or shell 6180 that is connected or
otherwise ed to the seal—forming structure or cushion 6200 (see Figs. 15 and
16). The shell 6180 may be permanently (e.g., co—molded, overmolded) or removably
(e. g., mechanical interlock) connected to the cushion 6200. In an example, the
cushion 6200 is constructed of a relatively flexible or pliable material (e.g., ne)
and the shell 6180 is constructed of a relatively rigid material (e.g., polycarbonate).
The shell 6180 and the cushion 6200 cooperate to form the plenum chamber 6500.
The shell 6180 includes an g 6305 by which breathable gas is delivered
to the plenum chamber 6500. The g 6305 is bounded by an r flange
6310 which is adapted to be connected to the frame assembly 6100 and adapted to
interface (e. g., seal) with the elbow assembly 6600 which is connected to the gas
delivery tube 4180.
The shell 6180 has multiple functions. For example, it forms the plenum
chamber for delivery of pressurised gases to the entrance of a patient’s airways. The
shell 6180 is a rigid structure that directs a force onto the seal—forming structure for
sealing to a patients face. The force is provided by tension forces from tightening the
headgear straps. These forces are translated from a pair of upper and lower headgear
straps to the corresponding upper and lower arms. In an example, the upper and lower
arms are provided the frame assembly, which provides the headgear tension forces to
the shell 6180.
The shell 6180 also provides an outer (or or) surface for engaging the
inner (or posterior) surface of the shroud of the frame assembly to effect a seal. The
shell also comprises separate retention features or is otherwise structured to
detachably engage to the inner surface of the frame assembly. The patient interface is
modular in that a single frame assembly size is capable of connection to multiple
n assembly sizes (e.g., small to large). Thus, the shell also detachably s
to the frame ly such that the frame ly is connected into a predetermined
uration that corresponds to its respective cushion assembly size. For example,
smaller cushion lies have an overall d height relative to medium or large
cushion assemblies. Thus the frame assembly ts in a position relative to the
cushion assembly to position the upper headgear attachment point in their correct
position (between the eyes and ears, while providing an attachment point where the
upper headgear straps avoid the ears). This means that the frame assembly ts
at a higher on on the shell when compared to medium or large cushion ly
sizes. In an example, medium and/or large sizes may not have this requirement and
connect such that the frame assembly is positioned in substantially the same position.
In the alternative example shown in Figs. 75 to 100, the cushion assembly
16175 includes shell 16180 that is connected or otherwise provided to the seal—
forming structure or cushion 16200 (see Figs. 73 and 74). The shell 16180 and the
cushion 16200 cooperate to form the plenum chamber 16500 (e.g., see Figs. 69 and
71). The shell 16180 includes an opening 16305 by which breathable gas is delivered
to the plenum chamber 16500. The opening 16305 is bounded by an annular flange
16310 which is adapted to connect to the frame assembly 16100.
In the nasal interface example, e.g., see Figs. 39 to 41, the cushion assembly
7175 includes a shell 7180 that is permanently (e.g., ded, overmolded)
connected to the seal—forming structure or cushion 7200. In an example, the cushion
7200 is constructed of a relatively flexible or pliable material (e.g., silicone) and the
shell 7180 is constructed of a relatively rigid material (e.g., polycarbonate). The shell
7180 and the cushion 7200 cooperate to form the plenum chamber 7500. In the
illustrated example, the flexible flange or lip seal 7250 (i.e. seal 7250 provides a seal
with the elbow assembly 7600) is provided in one—piece with the cushion 7200, e.g.,
connecting portion 7149 interconnects seal 7250 and cushion 7200 as shown in Figs.
38 and 39.
Connection Between n Assembly and Frame Assembly
In one form of the t technology, the shell 6180 of the cushion assembly
6175 is repeatedly engageable with and removably disengageable from the shroud
6110 of the frame assembly 6100 via a mechanical interlock, e.g., snap—fit connection.
The cushion assembly 6175 and the frame assembly 6100 e cooperating
retaining structures to connect the cushion assembly 6175 to the frame assembly
6100. In an example, the frame assembly 6100 is releasably connectable to the
cushion assembly 6175 to facilitate ement and/or cleaning, and to allow
alternative frame assemblies and cushion assemblies to be connected to one r.
Such arrangement allows multiple seals (e.g., types and sizes) to be used with the
patient interface and therefore provide a patient interface le for Multiple Patient
Multiple Use (MPMU) usage situations. In an alternative example, the frame
assembly 6100 may be permanently connected or integrally formed in one—piece with
the cushion assembly 6175, e.g., co—molded
In the illustrated example, the shell 6180 includes an opening 6305 bounded
by an annular flange 6310 that protrudes forwardly from the shell 6180. The flange
6310 includes a plurality of tabs or catches 6315 along its perimeter (e.g., see Figs. 15
and 17), e.g., 3, 4, 5 or more tabs, which are structured to engage or interlock with
corresponding spring arms 6125 on the posterior side of the shroud 6110, e.g., with a
snap—fit, to releasably connect the n assembly 6175 to the frame assembly 6100.
The cushion ly 6175 also includes one or more es 6320 (e.g., see
Figs. 15 and 17) along the ter of the flange 6310 (e.g., upper and lower
recesses) structured to engage or interlock with corresponding protrusions 6127 on the
ior side of the shroud 6110, e.g., to facilitate alignment, prevent relative
rotation.
In the illustrated example, the shell 6180 of the cushion assembly 6175 and the
shroud 6110 of the frame assembly 6100 are relatively rigid (e.g., both formed of a
relatively hard material, e.g., such as polycarbonate) such that engagement between
the shell 6180 and the shroud 6110 provides a hard—to—hard connection. Also, the
perimeter, shape, and geometry of the mating surfaces provided by the shell 6180 and
the shroud 6110 are predetermined to facilitate alignment and mechanical/structural
engagement, e.g., clean, smooth, curved mating es. That is, the relative rigidity
2016/050891
or stiffness of the shroud and the shell are to maintain the preformed ure of the
components. The stiffness allows for the components to maintain their shape so that
they may be easily aligned for connection.
It should be appreciated that the cushion assembly may be connected or
interlocked with the frame assembly in other suitable manners. For e, these
components may be connected via a clip.
In the alternative example, as best shown in Figs. 70 and 72, the inner annular
flange 16125 of the shroud 16110 extends through the opening 16305 of the shell
16180, and the tabs or catches 16127 of the flange 16125 engage or interlock on a
posterior side of the annular flange 16310 of the shell 16180 so as to releasably
connect the frame assembly 16100 to the cushion assembly 16175. Such tion
maintains ease of use, es a sealed hard to hard connection, minimizes ng
and rocking movement between components, and reduces impact on stability. Also,
such connection stably holds the cushion assembly 16175 in position, while allowing
the appropriate force vectors to be imparted onto the cushion ly 16175 for seal.
Also, the frame assembly 16100 is structured to form a static diametric seal
and a static face seal with the cushion assembly 16175 to minimize and l leak.
As illustrated in Figs. 70 and 72, the shroud 16110 of the frame assembly 16100
includes a channel adapted to receive the flange 16310 of the cushion assembly
16175. The leading edge 16310A of the flange 16310 and the end wall 16112A of the
channel are configured and arranged to provide a static face seal, and the outer side
16310B of the flange 16310 and the side wall 16112B of the channel are configured
and arranged to provide a static diametric seal.
In the nasal interface example, e.g., see Figs. 30 to 49, the shell 7180 includes
a plurality of tabs or catches 7315 along the ter of flange 7310, which are
structured to engage or interlock with corresponding tabs or arms 7125 on the
ior side of the shroud 7110, e.g., with a snap—fit, to releasably connect the
cushion ly 7175 to the frame assembly 7100.
The cushion assembly 7175 also includes one or more recesses 7320 (e.g., see
Fig. 41) along the perimeter of the flange 7310 (e.g., lower recess) structured to
engage or interlock with corresponding protrusions 7127 (e.g., see Fig. 43) on the
posterior side of the shroud 7110, e.g., to facilitate alignment, t relative
In another example, as shown in Figs. 55 to 58, the shell of the cushion
assembly 8175 may include a central aperture with an internal surface structured to
receive an annular central flange of the frame assembly 8100. The shell includes a
retention feature that interlocks or connects to a retention feature on the frame
assembly. In addition, a clearance is maintained within the aperture of the shell for a
bellows structure 8250 of a vent adaptor 8900 (Figs. 55 and 56) or elbow assembly
8600 (Figs. 57 and 58) to engage with a surface 8275 of the shell to effect a face seal.
The cushion assembly 6175 and the frame assembly 6100 are structured to
maintain engagement during use and prevent any unintentional or partial embly
during use.
In one form of the present technology, the frame assembly 6100 is engageable
with the cushion assembly 6175 by posteriorly moving the frame assembly 6100
towards the cushion assembly 6175 in a direction substantially parallel to the
Frankfort horizontal, and the frame assembly 6100 is disengageable from the cushion
assembly 6175 by anteriorly moving the frame assembly 6100 from the cushion
assembly 6175 in a direction substantially parallel to the Frankfort ntal.
Elbow Assembly
As shown in Figs. 27 and 28, the elbow assembly 6600 es a first end
portion 6610 that is repeatedly able with and removably disengageable from
the shroud 6110 of the frame assembly 6100 and a second end portion 6620 adapted
to connect to the air circuit 4170, e.g., via a swivel connector 6625.
The first end portion 6610 includes a pair of resilient, quick release pinch arms
6650, i.e., cantilevered spring arm. Each of the spring or pinch arms 6650 includes a
barbed end or tab 6652 structured to e a mechanical ock, e.g., snap—fit
connection, with the flange 6115 of the shroud 6110.
The first end portion 6610 includes an annular side wall 6630 structured to
extend through the frame assembly 6100 and form a seal with the cushion assembly
6175.
In the rated example, a vent 6700 is integrated into the first end portion
6610 to allow for the washout of exhaled air, e.g., vent exits of the vent provided
along a perimeter of the first end n 6610.
In the alternative example, as best shown in Figs. 59, 65, 70, and 72, the elbow
ly 16600 includes a first end portion 16610 with pinch arms 16650 to
releasably engage with the frame ly 16100 and a second end portion 16620
adapted to connect to the air circuit 4170, e.g., via a swivel connector 16625.
In this example, the first end portion 16610 includes inner and outer radial
walls 16630, 16640 defining a radial channel 16645 leading to a ity of vent
holes 16700 to permit the exit of exhausted gases from the patient interface.
In addition, the elbow assembly 16600 is structured to house an AAV
assembly including AAVs structured to allow the t to e through ports if
rized gas is not of sufficient magnitude or not delivered.
Figs. 50 and 51 show the elbow assembly 7600 structured for connection to
the nasal type patient interface 7000. Figs. 52 and 53 show an alternative elbow
assembly 9600 structured for connection to the nasal type patient interface 7000.
In the illustrated examples, each side of the elbow assembly 7600, 9600
includes a cantilevered push button and grooves along sides of the push button that
allow the push button to flex. Each push button includes a tab or catch that is adapted
to engage the edge of the opening 7105 of the frame assembly 7100 with a snap fit to
releasably secure the elbow assembly 7600, 9600 to the frame assembly 7100.
As best shown in Figs. 51 and 53, a raised portion of the button and webbing
within the grooves along sides of the button is constructed of a soft, tactile material,
e. g., TPE. The raised portion provides a soft e feel for ease of use and grip, and
the webbing provides seal, soft tactile feel, and spring (clip return) force. In an
e, the raised portion and webbing are overmolded to the main elbow body
including the push buttons.
As shown in Figs. 50 and 51, the elbow assembly 7600 includes a vent
assembly 7700 to allow for the washout of exhaled air.
Connection Between Elbow Assembly and Frame ly
The elbow assembly 6600 releasably connects and s onto the frame
assembly 6100 via the pinch arms 6650, e.g., quick release snap—fit. The flange 6115
of the shroud 6110 defines the circular channel 6120 which is structured to receive the
barbed end 6652 of the pinch arms 6650 to releasably retain the elbow assembly 6600
to the frame assembly 6100 and form a swivel connection (e.g., see Fig. 6), e.g., allow
360° free rotation of the elbow assembly 6600 ve to the frame assembly 6100.
Because the elbow assembly 6600 connects to the frame assembly 6100
independently of the cushion assembly 6175, the patient is able to remove and swap
different size cushion assemblies without the need for disconnecting the elbow
assembly 6600, frame assembly 6100, and headgear.
Similarly, in the alternative example as best shown in Fig. 72, the circular
channel 16120 of the frame assembly 16100 is structured to receive the barbed end
16652 of the pinch arms 16650 to releasably retain the elbow assembly 16600 to the
frame assembly 16100.
Seal Between Elbow Assembly and Cushion Assembly
In an example, the cushion assembly 6175 comprises a flexible flange or lip
seal 6250 to provide a seal with the elbow assembly 6600. The lip seal 6250 is
provided to the flange 6310 of the shell 6180 and includes a free end that extends
ly inwardly into the opening 6305. As shown in Fig. 13 and 14, the elbow
assembly 6600 is ured to mechanically interlock with the frame assembly 6100,
but is ured and arranged to sealingly engage with sealing membrane 6250 of the
cushion assembly 6175 to form a seal for the air flow path, i.e., sealing mechanism is
separate from the retention features.
As illustrated, the g edge of the side wall 6630 of the elbow assembly
6600 forms a face seal with the lip seal 6250. This form of engagement minimises
surface area contact to reduce friction, y allowing a seal to form between the
components while allowing the elbow assembly 6600 to swivel freely ve to the
frame and cushion assemblies 6100, 6175.
In the nasal interface example, e.g., see Figs. 37 and 38, the elbow ly
7600 is structured to mechanically interlock with the frame assembly 7100, and the
leading edge of the side wall 7630 of the elbow assembly 7600 is structured and
arranged to sealingly engage with the lip seal 7250 of the cushion assembly 7175 to
form a seal for the air flow path.
Seal Between Elbow Assembly and Frame Assembly
In an alternative example, the elbow assembly 16600 is ured to establish
a hard—to—hard connection and seal with the frame assembly 16100. As best shown in
Fig. 72, a dynamic diametric seal is formed between the cylindrical outer surfacc of
the outer wall 16640 of the elbow assembly 16600 and the inner surface provided by
the annular flanges 16115, 16125 of the frame assembly 16100. Also, the annular
flange 16125 of the frame assembly 16100 comprises the radially inwardly extending
ridge 16400 that acts as a stop to prevent over—insertion of the elbow assembly 16600
into the frame assembly 16100. The surface of the ridge 16400 also provides a
dynamic face seal with the leading edge or surface of the outer wall 16640 of the
elbow assembly 16600. The diametric seal and the face seal ed between
surfaces of the outer wall 16640 and surfaces of the annular flanges 16115,
16125/ridge 16400 e two mating surfaces of contact between the elbow
assembly 16600 and the frame ly 16100, which increases the surface area of
contact between the elbow assembly 16600 and the frame assembly 16100. The two
mating surfaces are configured and arranged to minimize and l leak by
providing a tortuous leak path, i.e., leak path between the two mating surfaces extends
radially to axially from interior the patient interface to atmosphere.
Lockout Feature
As noted above, the ridge 16400 of the frame assembly 16100 includes a
plurality of projections 16405 structured to provide a lockout feature to prevent direct
connection or insertion of the air circuit 4170 to the frame assembly 16100.
As best shown in Fig. 72, each projection 16405 s to the inner wall
16630 of the elbow assembly so that the projections 16405 do not extend significantly
into the inlet flow path to the t. In addition, each projection 16405 includes an
opening 16407 (e.g., see Figs. 72, 83, and 88) so the projections 16405 do not
icantly block outlet flow to the channel 16645 leading to the vent holes 16700 of
the elbow assembly 16100. Thus, the ity of projections 16405 are structured
and arranged to have minimal or no impact on noise (from flow through the opening
16105), impedance to air delivery (inlet flow to the patient), and C02 washout (outlet
flow to the vent of the elbow assembly 16100.
In an alternative example, as shown in Fig. 89A, each of the projections 16405
may be provided without an opening.
In another alternative, as shown in Fig. 89B, the lockout feature may be
provided by a single annular projection 16405 that extends along the entire perimeter
of the ridge 16400. As illustrated, openings 16407 are provided along the projection
16405, e.g., so the projection 16405 does not icantly block outlet flow to the
channel 16645 leading to the vent holes 16700.
Vent Adaptor Connector
In an alternative example, a vent adaptor connector may be provided to the
patient interface, e. g., as an alternative to the elbow assembly 6600. Similar to the
arrangement described above, the vent r connector may be ably
ted to the frame assembly 6100 independent of the cushion assembly 6175, and
may sealingly engage with the sealing membrane 6250 of the cushion assembly 6175
to form a seal for the air flow path.
Alternative Connection/Seal of Elbow Assembly/Vent r Connector
As aforementioned, the patient interface is table to both an elbow
assembly and a vent adaptor connector, e.g., elbow assembly/vent adaptor connector
releasably connected to the frame assembly and sealingly d with the cushion
assembly.
In an alternative e, as shown in Figs. 55 to 58, the elbow assembly
8600/vent adaptor tor 8900 includes a seal or bellows structure 8250 (e.g.,
formed of silicone) structured to engage an inner surface 8275 provided to the shell of
the cushion ly 8175. The bellows structure is structured to move s the
inner surface of the shell when pressure is increased within the components, i.e.,
pressure supported seal. The bellows structure engages with the inner surface on the
shell along the inlet opening to provide a bellows face seal.
The seal g structures of the vent adaptor connector/elbow assembly and
the shell are separate to the retention forming features. In an example, the frame
comprises a retention feature including a resilient pair of arms adapted for insertion
into corresponding grooves in the vent adaptor connector/elbow assembly. The
connection is also a swivel connection ng the vent r connector/elbow
assembly to swivel relative to the cushion assembly and frame assembly. Hence, the
bellows face seal has another advantage in that it effects a seal between the
components with minimal friction to allow substantial relative movement without
breaking seal. In an e, the frame assembly is structured such that it does not
form part of the air delivery path to the patient but is ured to removably retain
both the cushion assembly and vent adaptor connector/elbow assembly in position.
The vent adaptor connector/elbow assembly forms a seal directly with the shell of the
cushion assembly through an aperture provided in the frame assembly.
This configuration allows a user to remove the vent adaptor
connector/elbow assembly from the patient interface, without the need for
disconnecting the frame assembly from the cushion assembly, i.e., the patient can stop
therapy but leave the patient interface on the face. This configuration also allows a
user to remove the n assembly from the frame assembly and vent adaptor
connector/elbow assembly without the need for disconnecting the frame ly
from the vent adaptor connector/elbow assembly. In an e, the frame assembly
is connected to the headgear, thus the headgear can remain connected to the frame
assembly and vent adaptor connector/elbow ly while the user tries various
cushion assembly sizes (e.g., small, medium, large) t the need to reassemble
multiple components.
Modularity
In the illustrated example, the frame assembly 6100 may be provided in one
size (i.e., common frame assembly), which may be selectively engageable with
le sizes of cushion assemblies 6175, e.g., small, medium, and large size cushion
assemblies distinguished by volume/footprint on the patient’s face. Thus, the patient
has the freedom to change cushion sizes freely without the need to replace the frame
assembly 6100. In an example, regardless of size, the patient ace provides
similar locations for the headgear tors (e.g., based on headgear vectors and
clearance with the t’s eyes) and the connection for the elbow ly (e.g., to
optimize gas washout).
In such example, the shell of each of the different size cushion assemblies
includes a connector (annular flange—type connector) that is common or similar for all
sizes (e.g., common retention feature), which allows the one size or common frame
assembly to be connected to each of the different size cushion assemblies, i.e., each
cushion assembly es a common frame retention feature on the shell for all
cushion sizes.
Similar to the above, the frame assembly 7100 of the nasal interface type may
be provided in one size (i.e., common frame assembly), which may be selectively
engageable with multiple sizes of cushion assemblies 7175, e.g., small, medium, and
large size cushion. For example, Figs. 54A, 54B, and 54C are rear views of small,
medium, and large cushion assemblies 7175 according to an example of the present
logy. As illustrated, each size provides a different volume or footprint on the
t’s face.
.3.1 Seal-forming structure
In one form of the present technology, a seal—forming structure provides a
seal—forming surface, and may additionally provide a cushioning function.
A seal—forming ure in ance with the present technology may
be constructed from a soft, flexible, resilient material such as silicone. In an
alternative example, the seal—forming structure may include a foam cushion including
a foam seal forming portion. In such example, such foam n may be provided to
a shell to allow connection to the frame ly 6100.
In one form, the seal—forming structure comprises a sealing flange and a
support flange. The g flange comprises a relatively thin member with a
thickness of less than about 1mm, for example about 0.25mm to about 0.45mm, that
extends around the perimeter of the plenum chamber. t flange may be
relatively thicker than the sealing flange. The support flange is disposed between the
sealing flange and the marginal edge of the plenum chamber, and extends at least part
of the way around the perimeter. The support flange is or includes a spring—like
element and functions to support the sealing flange from buckling in use. In use the
sealing flange can readily respond to system pressure in the plenum chamber acting
on its ide to urge it into tight sealing engagement with the face.
In one form the seal—forming portion of the non—invasive patient interface
comprises a pair of nasal puffs, or nasal pillows, each nasal puff or nasal pillow being
constructed and arranged to form a seal with a respective naris of the nose of a
patient.
Nasal pillows in ance with an aspect of the present logy
e: a —cone, at least a portion of which forms a seal on an underside of the
t's nose, a stalk, a flexible region on the underside of the frusto—cone and
connecting the —cone to the stalk. In addition, the structure to which the nasal
pillow of the present technology is connected es a flexible region adjacent the
base of the stalk. The flexible regions can act in concert to facilitate a universal joint
structure that is accommodating of relative movement both displacement and angular
of the frusto—cone and the structure to which the nasal pillow is connected. For
example, the frusto—cone may be axially displaced towards the structure to which the
stalk is connected.
In one form, the non—invasive patient interface comprises a seal—forming
portion that forms a seal in use on an upper lip region (that is, the lip superior) of the
patient's face.
In one form the non—invasive patient interface comprises a seal—forming
portion that forms a seal in use on a chin—region of the patient's face.
[035 1] In certain forms of the present technology, a seal—forming ure is
configured to correspond to a particular size of head and/or shape of face. For
example one form of a seal—forming ure is suitable for a large sized head, but not
a small sized head. In another example, a form of seal—forming structure is suitable for
a small sized head, but not a large sized head.
.3.2 Plenum chamber
The plenum chamber has a perimeter that is shaped to be complementary
to the e contour of the face of an e person in the region Where a seal Will
form in use. In use, a marginal edge of the plenum chamber is positioned in close
proximity to an adjacent surface of the face. Actual contact with the face is provided
by the seal—forming structure. The seal—forming structure may extend in use about the
entire perimeter of the plenum chamber.
.3.3 Positioning and stabilising structure
The seal—forming structure of the patient ace of the present
technology may be held in sealing position in use by the positioning and stabilising
structure.
In one form of the present technology, a positioning and stabilising
structure is provided that is configured in a manner consistent with being worn by a
patient While sleeping. In one example the positioning and stabilising structure has a
low profile, or cross—sectional thickness, to reduce the perceived or actual bulk of the
apparatus. In one example, the positioning and stabilising ure comprises at least
one strap having a gular cross—section. In one example the positioning and
stabilising ure comprises at least one flat strap.
In one form of the present technology, a positioning and stabilising
ure 3300 comprises a strap constructed from a te of a fabric patient—
contacting layer, a foam inner layer and a fabric outer layer. In one form, the foam is
porous to allow moisture, (e.g., sweat), to pass through the strap. In one form, the
fabric outer layer comprises loop material to engage with a hook material portion.
In certain forms of the present technology, a positioning and stabilising
ure ses a strap that is extensible, e.g. resiliently extensible. For example
the strap may be configured in use to be in n, and to direct a force to draw a
cushion into sealing contact with a portion of a patient’s face. In an example the strap
may be configured as a tie.
In certain forms of the present logy, a positioning and stabilising
structure comprises a strap that is bendable and e.g. non—rigid. An advantage of this
aspect is that the strap is more table for a patient to lie upon while the patient is
sleeping.
In certain forms of the present technology, a positioning and stabilizing
structure provides a retaining force configured to correspond to a particular size of
head and/or shape of face. For example one form of positioning and stabilizing
structure provides a retaining force suitable for a large sized head, but not a small
sized head. In another example, a form of positioning and stabilizing structure
provides a retaining force suitable for a small sized head, but not a large sized head.
.3.4 Vent
In one form, the patient interface includes a vent constructed and arranged
to allow for the washout of d gases, e.g. carbon dioxide.
One form of vent in accordance with the present technology comprises a
plurality of holes, for example, about 20 to about 80 holes, or about 40 to about 60
holes, or about 45 to about 55 holes.
The vent may be located in the plenum chamber. Alternatively, the vent is
located in a decoupling structure, e.g., a swivel.
.3.5 Decoupling ure(s)
In one form the patient ace includes at least one decoupling
ure, for example, a swivel or a ball and socket.
.3.6 Connection port
Connection port allows for connection to the air circuit.
WO 49356
.3.7 ad support
In the illustrated example, the frame assembly 6100 is ed without a
forehead support.
In another form, the patient interface may include a forehead support, e.g.,
the frame assembly may include a forehead t.
.3.8 Anti-asphyxia valve
In one form, the patient interface includes an anti—asphyxia valve.
.3.9 Ports
In one form of the t technology, a patient interface includes one or
more ports that allow access to the volume within the plenum chamber. In one form
this allows a clinician to supply supplemental oxygen. In one form, this allows for the
direct measurement of a property of gases within the plenum chamber, such as the
pressure.
.4 RY
For the purposes of the present technology disclosure, in certain forms of
the present technology, one or more of the following tions may apply. In other
forms of the present technology, alternative definitions may apply.
.4.1 General
Air: In certain forms of the present technology, air may be taken to mean
atmospheric air, and in other forms of the present technology air may be taken to
mean some other combination of breathable gases, e.g. atmospheric air enriched with
oxygen.
Ambient: In certain forms of the present technology, the term ambient will
be taken to mean (i) external of the treatment system or patient, and (ii) immediately
surrounding the ent system or patient.
For example, ambient humidity with respect to a humidifier may be the
humidity of air immediately surrounding the humidifier, e.g. the humidity in the room
where a patient is sleeping. Such ambient humidity may be different to the humidity
outside the room where a patient is sleeping.
In another example, ambient pressure may be the pressure immediately
surrounding or external to the body.
In certain forms, ambient (e.g., ic) noise may be considered to be
the background noise level in the room where a patient is located, other than for
example, noise ted by an RPT device or ing from a mask or patient
interface. Ambient noise may be generated by sources outside the room.
Automatic Positive Airway Pressure (APAP) therapy: CPAP therapy in
which the treatment pressure is automatically adjustable, e.g. from breath to ,
between minimum and maximum , depending on the presence or absence of
indications of SDB .
Continuous Positive Airway Pressure (CPAP) therapy: Respiratory
pressure therapy in which the treatment pressure is approximately constant through a
respiratory cycle of a patient. In some forms, the pressure at the entrance to the
airways will be slightly higher during exhalation, and slightly lower during inhalation.
In some forms, the re will vary between different respiratory cycles of the
patient, for example, being increased in response to detection of indications of partial
upper airway obstruction, and decreased in the absence of indications of partial upper
airway ction.
Flow rate: The volume (or mass) of air delivered per unit time. Flow rate
may refer to an instantaneous quantity. In some cases, a reference to flow rate will be
a reference to a scalar quantity, namely a ty having magnitude only. In other
cases, a reference to flow rate will be a reference to a vector quantity, namely a
ty having both magnitude and direction. Flow rate may be given the symbol Q.
‘Flow rate’ is sometimes shortened to simply ‘flow’.
In the example of patient respiration, a flow rate may be nominally
positive for the inspiratory portion of a breathing cycle of a t, and hence
negative for the expiratory portion of the breathing cycle of a t. Total flow rate,
Qt, is the flow rate of air leaving the RPT device. Vent flow rate, Qv, is the flow rate
of air leaving a vent to allow washout of exhaled gases. Leak flow rate, Ql, is the flow
rate of leak from a patient interface system or elsewhere. atory flow rate, Qr, is
the flow rate of air that is received into the patient's respiratory system.
Leak: The word leak will be taken to be an unintended flow of air. In one
e, leak may occur as the result of an incomplete seal between a mask and a
patient's face. In another example leak may occur in a swivel elbow to the ambient.
Noise, conducted (acoustic): Conducted noise in the t document
refers to noise which is carried to the patient by the pneumatic path, such as the air
circuit and the patient interface as well as the air therein. In one form, conducted noise
may be quantified by measuring sound pressure levels at the end of an air circuit.
Noise, radiated (acoustic): Radiated noise in the present document refers
to noise which is carried to the patient by the ambient air. In one form, ed noise
may be fied by measuring sound power/pressure levels of the object in question
ing to ISO 3744.
Noise, vent (acoustic): Vent noise in the present document refers to noise
which is generated by the flow of air through any vents such as vent holes of the
patient interface.
Patient: A , whether or not they are suffering from a respiratory
disease.
[03 83] Pressure: Force per unit area. Pressure may be expressed in a range of
units, including cmHZO, g—f/cm2 and hectopascal. l cmHzO is equal to l g—f/cm2 and
is approximately 0.98 hectopascal. In this specification, unless otherwise stated,
pressure is given in units of cmHZO.
[03 84] The pressure in the patient ace is given the symbol Pm, while the
treatment pressure, which represents a target value to be achieved by the mask
pressure Pm at the current instant of time, is given the symbol Pt.
Respiratory Pressure Therapy (RPT): The application of a supply of air to
an entrance to the airways at a treatment pressure that is typically positive with
respect to atmosphere.
WO 49356
Ventilator: A mechanical device that provides pressure t to a
patient to perform some or all of the work of breathing.
.4.1.1 Materials
Silicone or Silicone Elastomer: A synthetic rubber. In this specification, a
reference to silicone is a reference to liquid silicone rubber (LSR) or a compression
moulded ne rubber (CMSR). One form of commercially available LSR is
SILASTIC (included in the range of products sold under this trademark),
manufactured by Dow Corning. Another manufacturer of LSR is Wacker. Unless
ise specified to the contrary, an exemplary form of LSR has a Shore A (or
Type A) indentation hardness in the range of about 35 to about 45 as measured using
ASTM D2240.
Polycarbonate: a typically transparent thermoplastic polymer of
Bisphenol—A Carbonate.
.4.1.2 Mechanical properties
[03 89] Resilience: Ability of a material to absorb energy when deformed
elastically and to release the energy upon ing.
o ‘Resilient’: Will e substantially all of the energy when unloaded.
Includes e.g. certain silicones, and thermoplastic elastomers.
Hardness: The ability of a material per se to resist deformation (e.g.
described by a Young’s s, or an ation hardness scale measured on a
standardised sample size).
0 ‘Soft’ materials may include silicone or thermo—plastic elastomer (TPE),
and may, e.g. y deform under finger pressure.
0 ‘Hard’ materials may include polycarbonate, polypropylene, steel or
aluminium, and may not e.g. readily deform under finger pressure.
[039l] Stifi‘ness (or ty) of a structure or component: The ability of the
structure or component to resist deformation in response to an applied load. The load
may be a force or a moment, e.g. compression, tension, bending or torsion. The
structure or component may offer ent ances in different directions.
0 ‘Floppy’ structure or component: A structure or component that will
change shape, e.g. bend, when caused to support its own weight, within a relatively
short period of time such as 1 second.
0 ‘Rigid’ structure or component: A structure or component that will not
substantially change shape when subject to the loads typically encountered in use. An
example of such a use may be setting up and maintaining a patient interface in sealing
relationship with an entrance to a patient's airways, e.g. at a load of approximately 20
to 30 cmHzO pressure.
As an example, an I—beam may comprise a ent bending stiffness
(resistance to a bending load) in a first direction in comparison to a ,
orthogonal direction. In another example, a structure or component may be floppy in a
first direction and rigid in a second direction.
.4.2 Respiratory cycle
Apnea: According to some definitions, an apnea is said to have occurred
when flow falls below a predetermined old for a duration, e.g. 10 seconds. An
obstructive apnea will be said to have occurred when, despite t effort, some
ction of the airway does not allow air to flow. A central apnea will be said to
have occurred when an apnea is detected that is due to a reduction in breathing effort,
or the absence of breathing effort, despite the airway being patent. A mixed apnea
occurs when a reduction or absence of breathing effort coincides with an obstructed
airway.
Breathing rate: The rate of neous respiration of a patient, y
measured in breaths per minute.
Duty cycle: The ratio of tion time, Ti to total breath time, Trot.
Efi‘ort (breathing): The work done by a spontaneously breathing person
attempting to breathe.
Expiratory portion ofa breathing cycle: The period from the start of
expiratory flow to the start of inspiratory flow.
Flow limitation: Flow limitation will be taken to be the state of affairs in a
t's respiration where an increase in effort by the patient does not give rise to a
corresponding increase in flow. Where flow limitation occurs during an inspiratory
portion of the breathing cycle it may be described as inspiratory flow limitation.
Where flow limitation occurs during an expiratory portion of the ing cycle it
may be described as expiratory flow limitation.
Types of flow limited inspiratory waveforms:
(i) Flattened: Having a rise ed by a vely flat portion, followed
by a fall.
(ii) M-shapedz Having two local peaks, one at the leading edge, and one at
the trailing edge, and a relatively flat portion between the two peaks.
(iii) Chair-shaped: Having a single local peak, the peak being at the
leading edge, followed by a relatively flat portion.
(iv) e-chair shaped: Having a relatively flat portion followed by
single local peak, the peak being at the trailing edge.
Hypopnea: According to some definitions, a hypopnea is taken to be a
reduction in flow, but not a cessation of flow. In one form, a ea may be said to
have occurred when there is a reduction in flow below a threshold rate for a duration.
A central hypopnea will be said to have occurred when a hypopnea is detected that is
due to a reduction in breathing effort. In one form in adults, either of the ing
may be ed as being hypopneas:
(i) a 30% reduction in patient ing for at least 10 seconds plus an associated 4%
desaturation; or
(ii) a reduction in patient breathing (but less than 50%) for at least 10 seconds, with an
associated desaturation of at least 3% or an arousal.
Hyperpnea: An increase in flow to a level higher than normal.
Inspiratory portion of a breathing cycle: The period from the start of
inspiratory flow to the start of expiratory flow will be taken to be the atory
n of a breathing cycle.
Patency (airway): The degree of the airway being open, or the extent to
which the airway is open. A patent airway is open. Airway patency may be
quantified, for example with a value of one (1) being patent, and a value of zero (0),
being closed (obstructed).
ve End-Expiratory Pressure (PEEP): The pressure above
atmosphere in the lungs that exists at the end of expiration.
Peakflow rate (Qpeak): The maximum value of flow rate during the
inspiratory portion of the respiratory flow waveform.
Respiratoryflow rate, patient airflow rate, respiratory airflow rate (Qr):
These terms may be understood to refer to the RPT device’s estimate of respiratory
airflow rate, as opposed to “true respiratory flow rate” or “true respiratory airflow
rate”, which is the actual respiratory flow rate experienced by the patient, usually
expressed in litres per minute.
Tidal volume (Vt): The volume of air inhaled or exhaled during normal
breathing, when extra effort is not applied.
ation) Time (Ti): The duration of the inspiratory n of the
respiratory flow rate waveform.
(exhalation) Time (Te): The duration of the expiratory portion of the
respiratory flow rate rm.
(total) Time (Ttot): The total duration between the start of one atory
portion of a respiratory flow rate waveform and the start of the following inspiratory
portion of the respiratory flow rate waveform.
[041 1] Typical recent ventilation: The value of ventilation around which recent
values of ventilation Vent over some ermined timescale tend to cluster, that is, a
measure of the central tendency of the recent values of ventilation.
Upper airway obstruction (UAO): includes both partial and total upper
airway obstruction. This may be associated with a state of flow limitation, in which
the flow rate increases only slightly or may even decrease as the re difference
across the upper airway increases (Starling resistor behaviour).
Ventilation (Vent): A measure of a rate of gas being exchanged by the
patient’s atory system. Measures of ation may include one or both of
inspiratory and expiratory flow, per unit time. When expressed as a volume per
minute, this quantity is often ed to as “minute ventilation”. Minute ventilation is
sometimes given simply as a volume, understood to be the volume per minute.
.4.3 Ventilation
Adaptive Servo-Ventilator (ASV): A servo—ventilator that has a
changeable, rather than fixed target ventilation. The changeable target ventilation may
be learned from some characteristic of the patient, for example, a respiratory
characteristic of the patient.
Backup rate: A parameter of a ator that establishes the minimum
breathing rate ally in number of breaths per minute) that the ventilator will
deliver to the patient, if not triggered by neous respiratory effort.
Cycled: The termination of a ventilator's inspiratory phase. When a
ventilator delivers a breath to a neously breathing patient, at the end of the
inspiratory portion of the breathing cycle, the ventilator is said to be cycled to stop
delivering the breath.
tory ve airway pressure (EPAP): a base pressure, to which a
pressure varying within the breath is added to produce the desired mask pressure
which the ventilator will attempt to achieve at a given time.
End expiratory pressure (EEP): Desired mask pressure which the
ventilator will attempt to achieve at the end of the expiratory portion of the breath. If
the pressure waveform template H(q>) is zero—valued at the end of expiration, i.e.
H(q>) = 0 when d) = l, the EEP is equal to the EPAP.
Inspiratory positive airway pressure (IPAP): Maximum desired mask
pressure which the ventilator will attempt to achieve during the inspiratory portion of
the breath.
Pressure support: A number that is tive of the increase in pressure
during ventilator inspiration over that during ventilator expiration, and lly
means the difference in re between the maximum value during inspiration and
the base pressure (e.g., PS 2 [PAP — EPAP). In some contexts pressure t
means the difference which the ventilator aims to achieve, rather than what it actually
achieves.
Servo-ventilator: A ventilator that measures patient ation, has a
target ventilation, and which adjusts the level of pressure support to bring the patient
ventilation towards the target ventilation.
Spontaneous/Timed (S/T): A mode of a ventilator or other device that
attempts to detect the tion of a breath of a spontaneously breathing patient. If
however, the device is unable to detect a breath within a predetermined period of
time, the device will automatically initiate delivery of the breath.
Swing: Equivalent term to pressure support.
Triggered: When a ventilator rs a breath of air to a spontaneously
breathing patient, it is said to be triggered to do so at the initiation of the respiratory
portion of the breathing cycle by the patient's efforts.
Typical recent ventilation: The typical recent ventilation Vtyp is the value
around which recent measures of ventilation over some predetermined timescale tend
to cluster. For e, a measure of the central tendency of the es of
ventilation over recent history may be a suitable value of a typical recent ventilation.
.4.4 Anatomy
.4.4.1 Anatomy of the face
Ala: the external outer wall or "wing" of each l (plural: alar)
Alare: The most lateral point on the nasal ala.
Alar curvature (or alar crest) point: The most posterior point in the
curved base line of each ala, found in the crease formed by the union of the ala with
the cheek.
Aaricle: The whole external e part of the ear.
(nose) Bony ork: The bony framework of the nose comprises the
nasal bones, the frontal process of the maxillae and the nasal part of the frontal bone.
[043 l] (nose) Cartilaginoas ork: The cartilaginous framework of the nose
comprises the septal, lateral, major and minor cartilages.
Colamella: the strip of skin that separates the nares and which runs from
the pronasale to the upper lip.
Colamella angle: The angle between the line drawn through the midpoint
of the nostril aperture and a line drawn perpendicular to the Frankfurt horizontal while
intersecting subnasale.
Frankfort horizontal plane: A line extending from the most inferior point
of the orbital margin to the left tragion. The tragion is the deepest point in the notch
superior to the tragus of the auricle.
Glabella: Located on the soft , the most ent point in the
midsagittal plane of the ad.
Lateral nasal cartilage: A generally triangular plate of cartilage. Its
superior margin is attached to the nasal bone and frontal process of the maxilla, and
its inferior margin is connected to the greater alar cartilage.
Lip, lower (labrale inferius):
Lip, upper (labrale superius):
Greater alar cartilage: A plate of cartilage lying below the lateral nasal
cartilage. It is curved around the or part of the naris. Its posterior end is
connected to the frontal process of the maxilla by a tough fibrous membrane
containing three or four minor cartilages of the ala.
Nares (Nostrils): Approximately ellipsoidal apertures forming the
entrance to the nasal . The singular form of nares is naris il). The nares are
separated by the nasal septum.
[044l] Nas0-labial sulcus 0r Nas0-labialfold: The skin fold or groove that runs
from each side of the nose to the comers of the mouth, separating the cheeks from the
upper lip.
Nas0-labial angle: The angle n the columella and the upper lip,
while intersecting subnasale.
0t0basi0n inferior: The lowest point of attachment of the auricle to the
skin of the face.
0t0basi0n superior: The highest point of attachment of the auricle to the
skin of the face.
Pronasale: the most protruded point or tip of the nose, which can be
fied in lateral view of the rest of the portion of the head.
Philtrnm: the midline groove that runs from lower border of the nasal
septum to the top of the lip in the upper lip region.
P0g0ni0n: Located on the soft , the most anterior midpoint of the
chin.
Ridge (nasal): The nasal ridge is the midline prominence of the nose,
extending from the Sellion to the Pronasale.
Sagittal plane: A vertical plane that passes from anterior (front) to
posterior (rear) dividing the body into right and left halves.
Sellion: Located on the soft tissue, the most e point overlying the
area of the frontonasal suture.
Septal cartilage (nasal): The nasal septal cartilage forms part of the
septum and divides the front part of the nasal cavity.
Sabalare: The point at the lower margin of the alar base, where the alar
base joins with the skin of the superior (upper) lip.
Subnasal point: Located on the soft tissue, the point at which the
columella merges with the upper lip in the midsagittal plane.
Sapramentale: The point of greatest concavity in the midline of the lower
lip between labrale inferius and soft tissue pogonion
.4.4.2 Anatomy of the skull
Frontal bone: The l bone includes a large vertical portion, the
squama lis, corresponding to the region known as the ad.
Mandible: The mandible forms the lower jaw. The mental protuberance is
the bony protuberance of the jaw that forms the chin.
Maxilla: The a forms the upper jaw and is located above the
mandible and below the orbits. The frontal process of the maxilla projects upwards by
the side of the nose, and forms part of its lateral ry.
Nasal bones: The nasal bones are two small oblong bones, varying in size
and form in different duals; they are placed side by side at the middle and upper
part of the face, and form, by their junction, the "bridge" of the nose.
Nasion: The intersection of the frontal bone and the two nasal bones, a
depressed area directly n the eyes and superior to the bridge of the nose.
Occipital bone: The occipital bone is situated at the back and lower part of
the cranium. It includes an oval aperture, theforamen magnum, through which the
cranial cavity communicates with the vertebral canal. The curved plate behind the
foramen magnum is the squama occipitalis.
[046l] Orbit: The bony cavity in the skull to contain the eyeball.
Parietal bones: The parietal bones are the bones that, when joined
together, form the roof and sides of the cranium.
Temporal bones: The al bones are ed on the bases and sides
of the skull, and support that part of the face known as the temple.
Zygomatic bones: The face includes two zygomatic bones, located in the
upper and lateral parts of the face and forming the ence of the cheek.
.4.4.3 Anatomy of the atory system
Diaphragm: A sheet of muscle that extends across the bottom of the rib
cage. The diaphragm separates the thoracic cavity, containing the heart, lungs and
ribs, from the abdominal cavity. As the diaphragm contracts the volume of the
thoracic cavity increases and air is drawn into the lungs.
Larynx: The larynx, or voice box houses the vocal folds and connects the
inferior part of the pharynx (hypopharynx) with the trachea.
Lungs: The organs of respiration in humans. The conducting zone of the
lungs contains the trachea, the bronchi, the bronchioles, and the terminal bronchioles,
The respiratory zone contains the respiratory bronchioles, the alveolar ducts, and the
alveoli.
Nasal cavity: The nasal cavity (or nasal fossa) is a large air filled space
above and behind the nose in the middle of the face. The nasal cavity is divided in two
by a vertical fin called the nasal septum. On the sides of the nasal cavity are three
horizontal wths called nasal conchae (singular "concha") or turbinates. To the
front of the nasal cavity is the nose, while the back blends, via the choanae, into the
nasopharynx.
Pharynx: The part of the throat situated immediately inferior to (below)
the nasal cavity, and superior to the oesophagus and larynx. The x is
conventionally divided into three sections: the arynx (epipharynx) (the nasal
part of the pharynx), the oropharynx (mesopharynx) (the oral part of the pharynx),
and the laryngopharynx (hypopharynx).
.4.5 Patient interface
Anti-asphyxia valve (AA V): The component or sub—assembly of a mask
system that, by g to atmosphere in a failsafe manner, reduces the risk of
excessive C02 rebreathing by a patient.
[047l] Elbow: An elbow is an example of a structure that directs an axis of flow
of air travelling therethrough to change direction h an angle. In one form, the
angle may be approximately 90 degrees. In another form, the angle may be more, or
less than 90 degrees. The elbow may have an approximately circular cross—section. In
r form the elbow may have an oval or a rectangular cross—section. In certain
forms an elbow may be rotatable with respect to a mating component, 6.g. about 360
degrees. In certain forms an elbow may be ble from a mating component, 6.g.
via a snap connection. In certain forms, an elbow may be assembled to a mating
component via a one—time snap during manufacture, but not removable by a patient.
Frame: Frame will be taken to mean a mask structure that bears the load
of tension between two or more points of connection with a headgear. A mask frame
may be a non—airtight load bearing ure in the mask. However, some forms of
mask frame may also be air—tight.
Functional dead space:
Headgear: Headgear will be taken to mean a form of positioning and
stabilizing structure designed for use on a head. For example the headgear may
comprise a tion of one or more , ties and stiffeners configured to locate
and retain a t interface in position on a patient’s face for delivery of respiratory
therapy. Some ties are formed of a soft, flexible, elastic material such as a laminated
composite of foam and fabric.
Membrane: Membrane will be taken to mean a typically thin t that
has, preferably, substantially no resistance to bending, but has resistance to being
stretched.
Plenum chamber: a mask plenum r will be taken to mean a portion
of a patient interface having walls at least partially enclosing a volume of space, the
volume having air therein pressurised above atmospheric pressure in use. A shell may
form part of the walls of a mask plenum chamber.
Seal: May be a noun form ("a seal") which refers to a structure, or a verb
form (“to seal”) which refers to the effect. Two elements may be constructed and/or
arranged to ‘seal’ or to effect ‘sealing’ therebetween without requiring a separate
‘seal’ element per se.
Shell: A shell will be taken to mean a curved, vely thin structure
having bending, tensile and ssive stiffness. For example, a curved structural
wall of a mask may be a shell. In some forms, a shell may be faceted. In some forms a
shell may be airtight. In some forms a shell may not be airtight.
Stifi‘ener: A stiffener will be taken to mean a structural component
designed to increase the bending resistance of another component in at least one
direction.
Strut: A strut will be taken to be a structural component designed to
increase the ssion resistance of another component in at least one direction.
[048l] Swivel (noun): A subassembly of components configured to rotate about a
common axis, preferably independently, preferably under low torque. In one form, the
swivel may be constructed to rotate through an angle of at least 360 degrees. In
another form, the swivel may be constructed to rotate through an angle less than 360
degrees. When used in the context of an air delivery conduit, the sub—assembly of
components preferably comprises a matched pair of rical conduits. There may
be little or no leak flow of air from the swivel in use.
Tie (noun): A structure designed to resist tension.
Vent: (noun): A structure that allows a flow of air from an or of the
mask, or conduit, to t air for clinically effective washout of exhaled gases. For
e, a clinically effective washout may involve a flow rate of about 10 litres per
minute to about 100 litres per , depending on the mask design and treatment
pressure.
.4.6 Shape of structures
Products in accordance with the present technology may comprise one or
more three—dimensional mechanical ures, for example a mask cushion or an
impeller. The three—dimensional structures may be d by two—dimensional
surfaces. These surfaces may be guished using a label to describe an associated
surface orientation, location, function, or some other characteristic. For example a
structure may comprise one or more of an anterior surface, a posterior surface, an
interior surface and an exterior surface. In another example, a cushion ure may
comprise a face—contacting (e.g. outer) surface, and a separate non—face—contacting
(e. g. underside or inner) surface. In r example, a ure may comprise a first
surface and a second surface.
To facilitate bing the shape of the three—dimensional structures and
the surfaces, we first consider a cross—section through a surface of the structure at a
point, p. See Fig. 3B to Fig. 3F, which illustrate examples of cross—sections at point p
on a surface, and the resulting plane curves. Figs. 3B to 3F also illustrate an outward
normal vector at p. The outward normal vector at p points away from the surface. In
some es we describe the e from the point of view of an imaginary small
person standing upright on the surface.
.4.6.1 Curvature in one dimension
The curvature of a plane curve at p may be described as having a sign
(6. g. positive, negative) and a magnitude (6.g. l/radius of a circle that just touches the
curve at p).
Positive curvature: If the curve at p turns towards the outward normal, the
curvature at that point will be taken to be positive (if the imaginary small person
leaves the point p they must walk uphill). See Fig. 3B (relatively large positive
curvature compared to Fig. 3C) and Fig. 3C (relatively small ve curvature
compared to Fig. 3B). Such curves are often referred to as concave.
Zero curvature: If the curve at p is a straight line, the curvature will be
taken to be zero (if the imaginary small person leaves the point p, they can walk on a
level, neither up nor down). See Fig. 3D.
Negative curvature: If the curve at p turns away from the d normal,
the curvature in that ion at that point will be taken to be negative (if the
imaginary small person leaves the point p they must walk downhill). See Fig. 3E
ively small negative curvature ed to Fig. 3F) and Fig. 3F (relatively large
negative curvature compared to Fig. 3E). Such curves are often referred to as convex.
.4.6.2 Curvature of two dimensional surfaces
A description of the shape at a given point on a two—dimensional surface
in accordance with the present technology may include multiple normal cross—
sections. The multiple cross—sections may cut the surface in a plane that includes the
outward normal (a “normal plane”), and each cross—section may be taken in a different
direction. Each cross—section results in a plane curve with a corresponding curvature.
The different curvatures at that point may have the same sign, or a different sign.
Each of the curvatures at that point has a magnitude, e.g. relatively small. The plane
curves in Figs. 3B to 3F could be examples of such multiple cross—sections at a
particular point.
Principal ures and directions: The directions of the normal planes
where the curvature of the curve takes its maximum and minimum values are called
the principal directions. In the examples of Fig. 3B to Fig. 3F, the maximum curvature
occurs in Fig. 3B, and the minimum occurs in Fig. 3F, hence Fig. 3B and Fig. 3F are
cross sections in the principal directions. The pal curvatures at p are the
curvatures in the principal directions.
Region ofa surface: A ted set of points on a e. The set of
points in a region may have similar characteristics, e.g. curvatures or signs.
Saddle region: A region where at each point, the pal curvatures have
opposite signs, that is, one is positive, and the other is negative (depending on the
direction to which the imaginary person turns, they may walk uphill or downhill).
Dome region: A region where at each point the principal curvatures have
the same sign, e.g. both ve (a “concave dome”) or both negative (a “convex
dome”).
2016/050891
Cylindrical region: A region where one principal curvature is zero (or, for
example, zero within cturing tolerances) and the other principal curvature is
l’lOl’l-ZCI'O.
Planar region: A region of a e where both of the principal
curvatures are zero (or, for example, zero within manufacturing tolerances).
Edge ofa e: A boundary or limit of a surface or region.
Path: In certain forms of the present technology, ‘path’ will be taken to
mean a path in the mathematical — topological sense, e.g. a continuous space curve
fromf(0) to f(l) on a surface. In certain forms of the present technology, a ‘path’ may
be described as a route or course, including e.g. a set of points on a surface. (The path
for the imaginary person is where they walk on the surface, and is analogous to a
garden path).
Path length: In certain forms of the present technology, ‘path length’ will
be taken to the distance along the surface from f(0) to f(l), that is, the distance along
the path on the surface. There may be more than one path between two points on a
surface and such paths may have different path lengths. (The path length for the
ary person would be the distance they have to walk on the surface along the
path).
Straight-line distance: The straight—line distance is the distance between
two points on a e, but without regard to the surface. On planar regions, there
would be a path on the surface having the same path length as the straight—line
ce between two points on the e. On non—planar es, there may be no
paths having the same path length as the straight—line distance between two points.
(For the imaginary person, the straight—line distance would correspond to the distance
‘as the crow flies’.)
.4.6.3 Space curves
Space carves: Unlike a plane curve, a space curve does not necessarily lie
in any particular plane. A space curve may be considered to be a one—dimensional
piece of three—dimensional space. An imaginary person walking on a strand of the
DNA helix walks along a space curve. A typical human left ear comprises a left—hand
helix, see Fig. 3P. A typical human right ear comprises a right—hand helix, see Fig.
3Q. Fig. 3R shows a right—hand helix. The edge of a structure, e.g. the edge of a
membrane or impeller, may follow a space curve. In general, a space curve may be
described by a curvature and a torsion at each point on the space curve. Torsion is a
measure of how the curve turns out of a plane. Torsion has a sign and a magnitude.
The torsion at a point on a space curve may be characterised with nce to the
tangent, normal and binormal vectors at that point.
Tangent unit vector (or unit tangent vector): For each point on a curve, a
vector at the point specifies a direction from that point, as well as a magnitude. A
tangent unit vector is a unit vector pointing in the same direction as the curve at that
point. If an ary person were flying along the curve and fell off her vehicle at a
particular point, the direction of the tangent vector is the direction she would be
travelling.
Unit normal vector: As the ary person moves along the curve, this
tangent vector itself changes. The unit vector pointing in the same direction that the
tangent vector is ng is called the unit principal normal vector. It is
perpendicular to the tangent vector.
Binormal unit : The binormal unit vector is perpendicular to both
the tangent vector and the principal normal vector. Its direction may be determined by
a right—hand rule (see e.g. Fig. 30), or alternatively by a left—hand rule (Fig. 3N).
Osculating plane: The plane containing the unit tangent vector and the
unit principal normal vector. See Figures 3N and 30.
Torsion ofa space curve: The torsion at a point of a space curve is the
magnitude of the rate of change of the binormal unit vector at that point. It measures
how much the curve es from the osculating plane. A space curve which lies in a
plane has zero n. A space curve which deviates a vely small amount from
the osculating plane will have a relatively small magnitude of torsion (e.g. a gently
sloping helical path). A space curve which deviates a relatively large amount from the
osculating plane will have a relatively large magnitude of torsion (e.g. a steeply
g helical path). With reference to Fig. 3R, since T2>Tl, the magnitude of the
torsion near the top coils of the helix of Fig. 3R is greater than the magnitude of the
torsion of the bottom coils of the helix of Fig. 3R
With reference to the right—hand rule of Fig. 30, a space curve turning
s the direction of the right—hand al may be ered as having a right—
hand positive torsion (e.g. a right—hand helix as shown in Fig. 3R). A space curve
turning away from the direction of the right—hand binormal may be considered as
having a right—hand negative torsion (e.g. a left—hand helix).
Equivalently, and with reference to a left—hand rule (see Fig. 3N), a space
curve turning s the direction of the left—hand al may be considered as
having a left—hand positive torsion (e.g. a left—hand helix). Hence left—hand positive is
equivalent to right—hand ve. See Fig. 38.
.4.6.4 Holes
A surface may have a one—dimensional hole, e.g. a hole bounded by a
plane curve or by a space curve. Thin structures (e.g. a membrane) with a hole, may
be described as having a one—dimensional hole. See for example the one dimensional
hole in the surface of structure shown in Fig. 31, bounded by the plane curve 301D.
A structure may have a two—dimensional hole, e.g. a hole bounded by a
surface. For example, an inflatable tyre has a two dimensional hole bounded by the
inside surface of the tyre. In another example, a bladder with a cavity for air or gel
could have a two—dimensional hole. See for example the cushion of Fig. 3L and the
example cross—section there through in Fig. 3M. In a yet another example, a conduit
may comprise a one—dimension hole (e.g. at its entrance or at its exit), and a two—
dimension hole bounded by the inside surface of the conduit. See also the two
dimensional hole through the ure shown in Fig. 3K, bounded by e 302D.
.5 OTHER REMARKS
[05 l l] A portion of the disclosure of this patent document contains al
which is subject to copyright tion. The copyright owner has no objection to the
facsimile reproduction by anyone of the patent nt or the patent disclosure, as it
appears in Patent Office patent files or records, but otherwise reserves all copyright
rights whatsoever.
Unless the context clearly dictates otherwise and where a range of values
is provided, it is understood that each intervening value, to the tenth of the unit of the
lower limit, between the upper and lower limit of that range, and any other stated or
ening value in that stated range is encompassed within the technology. The
upper and lower limits of these intervening ranges, which may be independently
included in the intervening ranges, are also encompassed within the technology,
subject to any specifically excluded limit in the stated range. Where the stated range
includes one or both of the limits, ranges excluding either or both of those ed
limits are also included in the technology.
Furthermore, where a value or values are stated herein as being
implemented as part of the technology, it is understood that such values may be
approximated, unless otherwise stated, and such values may be utilized to any suitable
significant digit to the extent that a practical technical implementation may permit or
require it.
Unless defined otherwise, all technical and scientific terms used herein
have the same meaning as commonly tood by one of ordinary skill in the art to
which this technology belongs. Although any methods and materials similar or
equivalent to those described herein can also be used in the practice or testing of the
present logy, a limited number of the exemplary methods and materials are
described herein.
When a ular material is identified as being used to construct a
ent, obvious alternative materials with similar properties may be used as a
substitute. rmore, unless specified to the contrary, any and all components
herein bed are understood to be capable of being manufactured and, as such,
may be manufactured together or separately.
It must be noted that as used herein and in the appended claims, the
ar forms a
, an", and "the" include their plural equivalents, unless the context
clearly dictates otherwise.
All publications mentioned herein are incorporated herein by reference in
their entirety to disclose and describe the methods and/or materials which are the
subject of those ations. The publications discussed herein are provided solely
for their sure prior to the filing date of the present application. Nothing herein is
to be construed as an admission that the present technology is not ed to te
such publication by virtue of prior invention. Further, the dates of publication
provided may be different from the actual publication dates, which may need to be
independently confirmed.
The terms "comprises" and ising" should be interpreted as
referring to ts, components, or steps in a non—exclusive manner, indicating that
the referenced elements, components, or steps may be present, or utilized, or
combined with other elements, components, or steps that are not expressly referenced.
The t headings used in the detailed description are included only for
the ease of reference of the reader and should not be used to limit the subject matter
found throughout the disclosure or the . The subject headings should not be
used in construing the scope of the claims or the claim limitations.
Although the technology herein has been described with reference to
ular examples, it is to be understood that these examples are merely illustrative
of the principles and applications of the technology. In some instances, the
terminology and symbols may imply specific details that are not required to practice
the technology. For example, although the terms "first" and "second" may be used,
unless otherwise specified, they are not intended to indicate any order but may be
utilised to distinguish between distinct elements. Furthermore, although process steps
in the methodologies may be described or illustrated in an order, such an ordering is
not required. Those skilled in the art will recognize that such ordering may be
modified and/or aspects thereof may be conducted rently or even
synchronously.
It is therefore to be understood that us modifications may be made
to the illustrative es and that other arrangements may be d without
departing from the spirit and scope of the technology.
For example, it should be iated that one or more features of any one
patient interface example (e.g., patient interfaces 6000, 7000, 16000) may be
combinable with one or more features of another patient interface example (e.g.,
patient interfaces 6000, 7000, 16000) or other examples related thereto. For
example, one or more aspects of the frame assembly 16100 (e.g., t feature,
headgear connector arms, connection and sealing arrangement between components)
may be incorporated into the patient interfaces 6000, 7000.
Also, it should be appreciated that one or more aspects of the present
technology may be combinable with one or more aspects of: PCT Application No.
, filed September 23, 2016 and entitled “Elbow Assembly”,
which claims the t of US. Provisional Application No. 62/222,435, filed
September 23, 2015 and US. Provisional Application No. 62/376,718, filed August
18, 2016; US. Provisional Application No. 62/377,217, filed August 19, 2016 and
entitled “Patient Interface with a Seal—Forming Structure having Varying Thickness”;
US. Provisional Application No. 62/377,158, filed August 19, 2016 and entitled
“Patient Interface with a Seal—Forming Structure having g Thickness”; PCT
ation No. , filed September 23, 2016 and entitled “Vent
Adaptor for a Respiratory y System”, which claims the benefit of US.
ional Application No. 62/222,604, filed September 23, 2015; and/or PCT
Application No. filed March 24, 2016 and entitled “Patient
Interface with Blowout Prevention for Seal—Forming Portion”, which claims the
benefit of US. Provisional Application No. 62/138,009, filed March 25, 2015 and
US. Provisional Application No. ,503, filed September 23, 2015; each of the
above—noted ations of which is orated herein by reference in its entirety.
.6 REFERENCE SIGNS LIST
Number Feature Item
1000 patient
1100 bed partner
3000 patient interface
3100 seal — forming structure
3200 plenum chamber
3300 positioning and stabilising structure
3400 vent
3600 connection port
3700 forehead support
4000 RPT device
4170 air circuit
5000 humidifier
6000 t interface
6100 frame assembly
6 105 opening
6110 shroud
6111 groove
6112 groove
6113 openings
6114 openings
6115 flange
6117 rnn
6120 channel
6125 spring arm
6127 protrusion
6130 upperheadgearconnecuu
6132 shroud connection portion
6133 pins
6134 upperheadgearconnecunfann
6135 upperheadgearconnecfionlxunt
6140 central flexible portion
6141 slot
6143 first rigid portion
6145 peripheral e portion
6146 slot
6147 secondiighlporfion
6150 knverheadgearconnecuu
6152 shroud connection portion
6153 pins
6154 knverheadgearconnecunfann
6155 ic connector
6156 receptacle
6160 headgearchp
6162 Inagnet
6175 cushion.assenibly
6180 shell
6200 seal — forming ure
6250 lip seal
6305 opening
6310 flange
6315 catch
6320 recess
6500 plenum chamber
6600 elbow assembly
6610 first end portion
6620 secondendlxufion
6625 sudvelconnecuu
6630 side wall
6650 pinch arm
6652 tab
6700 vent
6750 arnicover
6800 headgear
6802 upper side strap
6804 lower side strap
6806 crown strap
7000 patient interface
7100 franie assen1bly
7105 opening
7110 shroud
7125 spring arm
7127 sion
7130 headgearconnecun
7132 shroud tion portion
7133 intermediate portion
7134 upperheadgearconnecunfann
7135 slot
7140 flexible portion
7149 connecfingrxufion
7154 knyerheadgearconnecunfann
7155 magnetic connector
7160 headgearchp
7175 cushion.assen1bly
7180 shell
7200 seal — forming structure
7250 seal
7310 flange
7315 catch
7320 recess
7500 plenum r
7600 elbow assembly
7630 side wall
7700 vent assembly
7800 headgear
7802 upperheadgearsUap
7804 knyerheadgearSUap
8100 franie assen1bly
8175 cushion.assen1bly
8250 bellows structure
8275 surface
8600 elbow assembly
8900 ventadapUM?connector
9600 elbow assembly
16000 patient ace
16100 franie assen1bly
16105 opening
16110 shroud
16112A end wall
16112B side wall
16115 outer annular flange
16117 rnn
16120 channel
16125 innerannuhufiflange
16127 tab or catch
16132 shroud connection portion
16133 protrusion
16133A opening
16134 upperheadgearconnecknfann
16135 upperheadgearconnecfionlxnnt
16136 bfidge
16136A leading edge
16137 cap
16138 protrusion
16140 central flexible n
16141 slot
16145 peripheral flexible portion
16146 slot
16152 shroud connection portion
16153 protrusion
16153[\ opening
16154 knverheadgearconnecknfann
16155 magnetic connector
16155A magnet receiving portion
16155B Inagnet
16155C cover
16156 slot
16157 cap
16158 protrusion
16159 slot
16160 headgearchp
16162 Inagnet
16164 catch
16175 n.assen1bly
16180 shell
16200 seal — forming structure
16305 g
16310 flange
16310A leading edge
16310B outer side
16400 ridge
16405 pnflecfions
16407 opening
16450 upperanchor
16452 opening
16454 bridge member
16456 ribs
16460 loweranchor
16462 opening
16500 plenum chamber
16600 elbow assembly
16610 first end portion
16620 secondendrxufion
16625 connecun
16630 inneeraH
16640 outer wall
WO 49356
16645 channel
16650 pinch arm
16652 barbed end
16700 vent holes
16750 arm cover
16800 headgear
16802 upper side strap
16803 tab
16804 lower side strap
16806 crown strap
17 1 10 shroud
17134 connector arm
17 154 lower arm
17 157 cap
17450 anchor
6
Claims (16)
1. A patient interface for sealed ry of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to a patient’s airways including at least entrance of a patient’s nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 4 cmH2O to about 30 cmH2O above ambient air re in use, throughout a patient’s atory cycle, while the t is sleeping, to ameliorate sleep disordered breathing; said t interface comprising: a frame assembly including a shroud and connectors provided to the shroud, the connectors operatively able to headgear; a cushion assembly provided to the frame assembly, the cushion assembly including a shell and a seal-forming structure provided to the shell and structured to form a seal with a patient’s nose and/or mouth, the shell and the seal-forming structure cooperating to form a plenum chamber pressurizable to the therapy pressure, and the shell includes a circular inlet opening structured to receive the flow of air at the therapy pressure for breathing by the patient; an air delivery connector provided to the frame assembly, the air ry tor operatively connected to an air delivery tube for supplying the flow of air at the therapy pressure along an air flow path to the plenum chamber, n the cushion assembly is structured to releasably connect to the frame assembly independently of the air delivery connector, wherein the shell of the n assembly and the shroud of the frame assembly each comprise a relatively hard material that is more rigid than the orming structure such that engagement between the shell and the shroud provides a hard-to-hard tion, wherein the air delivery connector is structured to releasably connect to the frame assembly independently of the cushion assembly, wherein a first seal for the air flow path is formed between the air delivery connector and the frame assembly, and a separate second seal is formed between the frame assembly and the cushion assembly, and wherein the first seal ses a dynamic diametric seal and a dynamic face seal, and the second seal comprises a static diametric seal and a static face seal.
2. The patient interface according to claim 1, n the air delivery connector includes a pair of quick release spring arms structured and arranged to releasably connect to the frame assembly.
3. The patient ace according to claim 1 or claim 2, wherein the frame assembly includes an upper headgear connector structured to connect to upper straps of the headgear and a lower headgear connector structured to t to lower straps of the headgear.
4. The patient interface according to claim 3, wherein the upper headgear tor includes a pair of upper headgear connector arms, each of the upper headgear connector arms ing one or more flexible portions structured and arranged to m to varying facial profiles.
5. The patient interface according to claim 4, wherein each of the flexible portions includes one or more slots structured to form one or more hinges.
6. The patient ace according to any one of claims 3 to 5, wherein the lower headgear connector includes a pair of lower headgear tor arms, each of the lower headgear connector arms including a magnetic connector structured to t to a magnetic headgear clip.
7. The patient interface according to claim 6, wherein each of the lower headgear connector arms comprises a slot structured to form a hinge portion.
8. The patient interface according to any one of claims 1 to 7, wherein the frame assembly is provided in one size and is structured to be selectively engageable with multiple sizes of the cushion assembly.
9. The patient interface according to any one of claims 1 to 8, wherein the frame assembly includes a lockout feature along the air flow path structured and arranged to prevent direct connection or insertion of the air delivery tube.
10. The patient interface according to claim 9, wherein the lockout feature comprises a plurality of projections structured and arranged to extend towards the air flow path.
11. The patient ace according to claim 9, wherein the lockout feature comprises a single annular projection structured and arranged to extend towards the air flow path.
12. The patient interface according to any one of claims 1 to 11, wherein the air delivery connector es an elbow assembly.
13. The patient ace according to claim 12, wherein the elbow ly is d to swivel relative to the frame assembly.
14. The patient interface according to claim 12 or claim 13, wherein the elbow assembly comprises a plurality of vent holes and an anti-asphyxia valve assembly.
15. The patient interface according to claim 1 to 14, wherein the frame assembly is provided in the air flow path.
16. A treatment system used for treatment of sleep ered breathing, comprising: the t interface according to any one of claims 1 to 15; a respiratory pressure therapy (RPT) device to supply breathable gas at positive pressure; and an air delivery tube to pass the breathable gas from the RPT device to the patient interface. WO 49356
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ770246A NZ770246A (en) | 2015-09-23 | 2016-09-23 | Patient interface |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562222593P | 2015-09-23 | 2015-09-23 | |
US62/222,593 | 2015-09-23 | ||
US201662376961P | 2016-08-19 | 2016-08-19 | |
US62/376,961 | 2016-08-19 | ||
PCT/AU2016/050891 WO2017049356A1 (en) | 2015-09-23 | 2016-09-23 | Patient interface |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ740771A NZ740771A (en) | 2020-12-18 |
NZ740771B2 true NZ740771B2 (en) | 2021-03-19 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230233787A1 (en) | Patient interface | |
US11672936B2 (en) | Elbow assembly | |
US11666721B2 (en) | Oro-nasal patient interface | |
US20210346630A1 (en) | Patient interface with volume reducing member | |
US11833307B2 (en) | Connector assembly for a patient interface | |
US11931512B2 (en) | Oro-nasal patient interface | |
US20220323705A1 (en) | Modular headgear | |
US20220401680A1 (en) | Conduit headgear | |
US20240050684A1 (en) | Connector assembly | |
NZ740771B2 (en) | Patient interface |